<SEC-DOCUMENT>0001213900-25-002639.txt : 20250110
<SEC-HEADER>0001213900-25-002639.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110160512
ACCESSION NUMBER:		0001213900-25-002639
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20250107
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250110
DATE AS OF CHANGE:		20250110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amesite Inc.
		CENTRAL INDEX KEY:			0001807166
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				823431717
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39553
		FILM NUMBER:		25522871

	BUSINESS ADDRESS:	
		STREET 1:		205 EAST WASHINGTON STREET
		STREET 2:		SUITE B
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48104
		BUSINESS PHONE:		(650) 516-7633

	MAIL ADDRESS:	
		STREET 1:		205 EAST WASHINGTON STREET
		STREET 2:		SUITE B
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Amesite Operating Co
		DATE OF NAME CHANGE:	20200318
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0227073-8k_amesite.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:VDE0="http://amesite.com/20250107">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_VDE0_amesite.com_20250107 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20250107_20250107 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001807166 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000004" name="dei:EntityCentralIndexKey">0001807166</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="vde0-20250107.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-01-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001807166</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-07</xbrli:startDate>
        <xbrli:endDate>2025-01-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_90A_edei--DocumentType_c20250107__20250107_zkwkDM6vYTDi"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 OR 15(d) of The
Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):&#160;<b><span id="xdx_909_edei--DocumentPeriodEndDate_c20250107__20250107_zjNG1nQVFQ0f"><ix:nonNumeric contextRef="AsOf2025-01-07" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">January
7, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20250107__20250107_zuCSAoGbniY5"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000011" name="dei:EntityRegistrantName">Amesite Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20250107__20250107_zYw5hvCZSWs3"><ix:nonNumeric contextRef="AsOf2025-01-07" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--EntityFileNumber_c20250107__20250107_zde4LOXvqpn5"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000013" name="dei:EntityFileNumber">001-39553</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20250107__20250107_z6nFZG37QQvh"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000014" name="dei:EntityTaxIdentificationNumber">82-3431718</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</p></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20250107__20250107_zpJzrps1qOV3"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000015" name="dei:EntityAddressAddressLine1">607 Shelby Street</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine2_c20250107__20250107_ziZEV95O5qDb"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 700 PMB 214</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20250107__20250107_zlRyatdhQg94"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000017" name="dei:EntityAddressCityOrTown">Detroit</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20250107__20250107_zZT5B9FkOabi"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000018" name="dei:EntityAddressStateOrProvince">MI</ix:nonNumeric></span></b></p></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20250107__20250107_zEeGXMm3tI0d"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000019" name="dei:EntityAddressPostalZipCode">48226</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code:&#160;<b>(<span id="xdx_909_edei--CityAreaCode_c20250107__20250107_zE1OJKiJVtlk"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000020" name="dei:CityAreaCode">734</ix:nonNumeric></span>) <span id="xdx_900_edei--LocalPhoneNumber_c20250107__20250107_zPUcqIVDrtd4"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000021" name="dei:LocalPhoneNumber">876-8130</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--WrittenCommunications_c20250107__20250107_zmNJjiRuZqbd"><ix:nonNumeric contextRef="AsOf2025-01-07" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--SolicitingMaterial_c20250107__20250107_zGVm6DLQp9Zc"><ix:nonNumeric contextRef="AsOf2025-01-07" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20250107__20250107_zQYI0BFXM6k6"><ix:nonNumeric contextRef="AsOf2025-01-07" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20250107__20250107_zi7bOH0oKhLb"><ix:nonNumeric contextRef="AsOf2025-01-07" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Title&#160;of&#160;each&#160;class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading&#160;Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Name&#160;of&#160;each&#160;exchange&#160;on&#160;which&#160;registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20250107__20250107_zcMqLZ7MNoV8"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20250107__20250107_zI9vGzTsl7Tb"><ix:nonNumeric contextRef="AsOf2025-01-07" id="Fact000027" name="dei:TradingSymbol">AMST</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The <span id="xdx_900_edei--SecurityExchangeName_c20250107__20250107_zkMR6p01Ya1b"><ix:nonNumeric contextRef="AsOf2025-01-07" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company&#160;<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--EntityEmergingGrowthCompany_c20250107__20250107_zjBtjnleWsC6"><ix:nonNumeric contextRef="AsOf2025-01-07" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_edei--EntityExTransitionPeriod_c20250107__20250107_zxfx4mNIgNdh"><ix:nonNumeric contextRef="AsOf2025-01-07" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 &#160;Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On January
7, 2025, Amesite Inc. (the &#8220;Company&#8221;) entered into an&#160;underwriting&#160;agreement&#160;(the &#8220;Underwriting&#160;Agreement&#8221;)
with Laidlaw &amp; Company (UK) Ltd. (&#8220;Laidlaw&#8221;), as representatives of the several underwriters listed in <span style="text-decoration: underline">Schedule I</span>
thereto (collectively, the &#8220;Underwriters&#8221;), to issue and sell 1,201,667 shares (the &#8220;Shares&#8221;) of the Company&#8217;s
common stock, $0.0001 par value per share (&#8220;Common Stock&#8221;), at a purchase price of $3.00 per Share. The Shares were offered
by the Company pursuant to its shelf registration statement on Form S-3 (File No. 333-282999), which was declared effective by the Securities
and Exchange Commission on December 18, 2024, on a best efforts basis (the &#8220;Offering&#8221;). The offer and sale of the Shares in
the Offering are described in the Company&#8217;s prospectus constituting a part of the Registration Statement, as supplemented by a final
prospectus supplement dated January 7, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">As part
of the Offering, the Company agreed to issue the Underwriters, or their designees, in their individual capacity and not as the representative
of the Underwriters, warrants (the &#8220;Underwriters&#8217; Warrants&#8221;) to purchase a number of shares of Common Stock equal to
five percent (5%) of the number of Shares sold to the public (up to an aggregate of 60,0,83 shares) at an at an exercise price equal to
125.0% of the offering price per share of Common Stock, or $3.75 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Underwriting&#160;Agreement&#160;contains
customary representations, warranties and agreements of the Company, customary conditions to closing, obligations of the parties and termination
provisions. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Pursuant
to the&#160; Underwriting&#160;Agreement, the Company and its officers and directors agreed to a 30-day &#8220;lock-up&#8221; period with
respect to sales of specified securities, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The foregoing
descriptions of the Underwriting Agreement, and the form of Underwriters&#8217; Warrant are not complete and are qualified in their entirety
by reference to the full text of the form of the Underwriting Agreement and the form of Underwriters&#8217; Warrant, copies of which are
filed as Exhibits 1.1, and 4.1, respectively, to this Current Report on Form 8-K and are incorporated by reference herein.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Sheppard Mullin
Richter &amp; Hampton LLP, counsel to the Company, has issued an opinion to the Company with respect to the validity of the Shares to
be issued and sold in the Offering, a copy of which is filed as Exhibit 5.1 to this Current Report on Form 8-K.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 8, 2025, the <span style="background-color: white">Company&#160;closed&#160;the
Offering</span>, and the Company sold 1,201,667 Shares to the Underwriters for total gross proceeds of approximately $3.6 million. After
deducting the underwriting discounts, commission and expenses and estimated offering expenses payable by the Company, the Company received
net proceeds of approximately $3.08 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 3.02 Unregistered
Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Reference is made to
the disclosure under Item 1.01 above which is hereby incorporated in this Item 3.02 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Underwriters&#8217; Warrants
and the shares issuable upon exercise of the Underwriters&#8217; Warrants have not been registered under the Securities Act of 1933, as
amended (the &#8220;Securities Act&#8221;), or the securities laws of any state, and are being offered and sold in reliance on the exemption
from registration under the Securities Act, afforded by Section 4(a)(2) and/or Rule 506 promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 7.01 Regulation FD Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 6, 2025, the Company issued a press
release announcing that it had launched the Offering On January 7, 2025, the Company issued a press release announcing that it had priced
the Offering. On January 8, 2025, the Company issued a press release announcing that it had closed the Offering. Copies of these press
releases are furnished as Exhibits 99.1, 99.2 and 99.3, respectively, to this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><b>Item 8.01 Other Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">As previously reported in a Current Report on
Form 8-K filed by the Company, on November 26, 2024, the Company <span style="color: #212529; background-color: white">received a deficiency
letter (the &#8220;Nasdaq Letter&#8221;) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum
of $2,500,000 in stockholders&#8217; equity for continued listing on the Nasdaq Capital Market (the &#8220;Stockholders&#8217; Equity
Requirement&#8221;), nor is it in compliance with either of the alternative listing standards, either a market value of listed securities
of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of
the three most recently completed fiscal years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the Offering described under Item 1.01
above, the Company believes, as of the date of this filing, that it has stockholders&#8217; equity in excess of $2,500,000, and has thereby
regained compliance with the Nasdaq Stockholders&#8217; Equity Requirement. The Company awaits Nasdaq&#8217;s confirmation of the same.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 &#160;Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: top; width: 9%"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="white-space: nowrap; vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; width: 90%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">1.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea022707301ex1-1_amesite.htm">Underwriting Agreement, dated January 7, 2025, by and between the Company and Laidlaw &amp; Company (UK) Ltd., as representative of the several underwriters listed in Schedule I thereto.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea022707301ex4-1_amesite.htm">Form of Underwriters&#146; Warrant</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">5.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea022707301ex5-1_amesite.htm">Opinion of Sheppard Mullin Richter &amp; Hampton LLP</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">23.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea022707301ex5-1_amesite.htm">Consent of Sheppard Mullin Richter &amp; Hampton LLP (included in Exhibit 5.1 filed herewith)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea022707301ex99-1_amesite.htm">Press release dated January 6, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">99.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea022707301ex99-2_amesite.htm">Press release dated January 7, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">99.3</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea022707301ex99-3_amesite.htm">Press release dated January 8, 2025</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>AMESITE INC.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 36%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Date: January 10, 2025</span></td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt">/s/ Ann Marie Sastry, Ph.D.</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Ann Marie Sastry, Ph.D.</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-3-</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OXKVJPAxqYgsQiR6XXSKJd2R2c3sk/rLNiUaBmaGe89cIWZiSxvdIMNlVeRQYts1yiEUeEVGU6F3ZLt9Cn4WeNPWsTJuPH9gRp5BzyTzeFF5YbT22mKdgoxCuQzjxC+pXMLpIIKvnpG56hqN06oBZWo4MXWs0Sl+TR9KNZCh9jVGnZGtJpNCNJeT/IZYRjEcqVdP4ruFPM9EMBsrEFumR+dd68Gh+ZKwbrD1cXai/x18AAcgSo0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea022707301ex1-1_amesite.htm
<DESCRIPTION>UNDERWRITING AGREEMENT, DATED JANUARY 7, 2025, BY AND BETWEEN THE COMPANY AND LAIDLAW & COMPANY (UK) LTD., AS REPRESENTATIVE OF THE SEVERAL UNDERWRITERS LISTED IN SCHEDULE I THERETO
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMESITE
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock and Pre-Funded Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>UNDERWRITING
AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
7, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Laidlaw
&amp; Company (UK) Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">521
Fifth Avenue, 12<SUP>th</SUP>&nbsp;Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10175</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>As
Representative of the several<BR>
Underwriters named in&nbsp;<U>Schedule I</U>&nbsp;attached hereto<BR>
&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amesite
Inc. (f/k/a Amesite Operating Company), a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), subject to the terms and conditions
herein, proposes to sell to the underwriters (the &ldquo;<B>Underwriters</B>&rdquo;) named in&nbsp;<U>Schedule I</U>&nbsp;attached to
this agreement (this &ldquo;<B>Agreement</B>&rdquo;), on a best efforts basis, (a) up to 1,201,667 shares (the &ldquo;<B>Shares</B>&rdquo;)
of the Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;) and (b) pre-funded warrants
(the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;) to purchase up to an aggregate of 0shares of Common Stock at an exercise price of $0.0001
per share (the &ldquo;<B>Pre-Funded Warrant Shares</B>&rdquo; and, collectively with the Shares and the Pre-Funded Warrants, the &ldquo;<B>Securities</B>&rdquo;),
such Pre-Funded Warrants to have the terms and conditions described in the Prospectus (as defined below) and to otherwise be in form
and substance reasonably acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also proposes to issue to the Underwriters, or their respective designees, in their individual capacity and not as the Representative
(as defined below) of the several Underwriters, warrants (the &ldquo;<B>Underwriter Warrants</B>&rdquo; and, collectively with the Pre-Funded
Warrants, the &ldquo;<B>Warrants</B>&rdquo;) to purchase up to an aggregate number of shares of Common Stock equal to five percent (5.0%)
of the number of Shares sold to the public and of the number of Pre-Funded Warrant Shares issuable upon exercise of the Pre-Funded Warrants
sold to the public (up to an aggregate of [*] shares) (the &ldquo;<B>Underwriter Warrant Shares</B>&rdquo; and, collectively with the
Pre-Funded Warrant Shares, the &ldquo;<B>Warrant Shares</B>&rdquo;), allocated equally between them, such Underwriter Warrants to have
the terms and conditions described in the Prospectus and to otherwise be in form and substance reasonably acceptable to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is understood that the Underwriters are to make a &ldquo;best efforts&rdquo; public offering of the Securities as soon as the Representative
deems it advisable to do so. The Shares are to be sold to the public at the public offering price per Share set forth in the Prospectus,
and the Pre-Funded Warrants are to be sold to the public at the public offering price per Share set forth in the Prospectus minus $0.0001.
The Company recognizes that &ldquo;best efforts&rdquo; does not assure that the offering of the Securities will be consummated and it
is understood between the parties that there is no firm commitment by the Underwriters to purchase any or all of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <I>Representations,
Warranties and Agreements of the Company</I>. The Company represents, warrants and agrees with each of the Underwriters that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) A
registration statement on Form S-3 (File No. 333-282999) relating to the Securities, including a related base prospectus has (i)&nbsp;been
prepared by the Company in conformity with the requirements of the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;),
and the rules and regulations of the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) thereunder (the &ldquo;<B>Rules
and Regulations</B>&rdquo;); (ii)&nbsp;been filed with the Commission under the Securities Act and is not proposed to be amended; and
(iii)&nbsp;become effective under the Securities Act. Copies of such registration statement and any amendment thereto have been delivered
by the Company to you as the representative (the &ldquo;<B>Representative</B>&rdquo;) of the Underwriters. As used in this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &ldquo;<B>Applicable
Time</B>&rdquo; means 8:00 a.m.. (New York City time) on January 72025;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) &ldquo;<B>Effective
Date</B>&rdquo; means the date and time as of which the Registration Statement, or the most recent post-effective amendment thereto,
became effective in respect of the Underwriters pursuant to Rule 430B(f)(2) under the Rules and Regulations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) &ldquo;<B>Issuer
Free Writing Prospectus</B>&rdquo; means any &ldquo;issuer free writing prospectus&rdquo; (as defined in Rule 433 under the Securities
Act) relating to the offering of the Securities in the fginal form filed or required to be filed with the Commission or, if not required
to be filed, in the form retained in the Company&rsquo;s records pursuant to Rule 433(g);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) &ldquo;<B>Preliminary
Prospectus</B>&rdquo; means any preliminary prospectus relating to the Securities, including the documents incorporated or deemed to
be incorporated by reference therein under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;) pursuant
to Item 12 of Form S-3 under the Securities Act, filed by the Company with the Commission with the consent of the Underwriters pursuant
to Rule 424(b) of the Rules and Regulations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) &ldquo;<B>Pricing
Disclosure Package</B>&rdquo; means, as of the Applicable Time, the most recent Preliminary Prospectus, together with the information
included in&nbsp;<U>Schedule II</U>&nbsp;hereto and each Issuer Free Writing Prospectus filed or used by the Company on or before the
Applicable Time, other than a road show that is an Issuer Free Writing Prospectus but is not required to be filed under Rule 433 of the
Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) &ldquo;<B>Prospectus</B>&rdquo;
means the final prospectus, in the form first furnished or made available to the Underwriters for use in connection with the offering
of the Securities, including the documents incorporated or deemed to be incorporated by reference therein under the Exchange Act pursuant
to Item 12 of Form S-3 under the Securities Act, as filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) &ldquo;<B>Registration
Statement</B>&rdquo; means the shelf registration statement on Form S-3, File No. 333-282999, as amended by any post-effective amendments
thereto to such time, including any exhibits and schedules thereto at such time, the documents incorporated to deemed to be incorporated
by reference therein under the Exchange Act at such time pursuant to Item 12 of Form S-3 under the Securities Act and documents otherwise
deemed to be a part thereof as of such time pursuant to Rule 430B under the Rules and Regulations (&ldquo;<B>Rule 430B</B>&rdquo;);&nbsp;<I>provided</I>,&nbsp;<I>however</I>,
that the &ldquo;Registration Statement&rdquo; without reference to a time means such registration statement as amended by any post-effective
amendments thereto as of the time of the first contract of sale for the Securities, which time shall be considered the &ldquo;new effective
date&rdquo; of such registration statement with respect to the Securities within the meaning of paragraph (f)(2) of Rule 430B, including
the exhibits and schedules thereto as of such time, the documents incorporated or deemed incorporated by reference therein under the
Exchange Act at such time pursuant to Item 12 of Form S-3 under the Securities Act and the documents otherwise deemed to be a part thereof
as of such time pursuant to Rule 430B;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii) &ldquo;<B>Testing-the-Waters
Communication</B>&rdquo; means any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the
Securities Act; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
&ldquo;<B>Written Testing-the-Waters Communication</B>&rdquo; means any Testing-the-Waters Communication that is a &ldquo;written communication&rdquo;
within the meaning thereof set forth in Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
reference to the &ldquo;<B>most recent Preliminary Prospectus</B>&rdquo; shall be deemed to refer to the latest Preliminary Prospectus
filed pursuant to Rule 424(b) of the Rules and Regulations prior to or on the date of this Agreement. Any reference herein to the term
&ldquo;<B>Registration Statement</B>&rdquo; shall be deemed to include the abbreviated registration statement to register additional
Securities under Rule 462(b) of the Rules and Regulations (the &ldquo;<B>Rule 462(b) Registration Statement</B>&rdquo;). The Commission
has not issued any order preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending the effectiveness
of the Registration Statement, including any Rule 462(b) Registration Statement, and no proceeding or examination for such purpose has
been instituted or threatened by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Company was not at the time of initial filing of the Registration Statement, is not on the date hereof and will not be on the Delivery
Date (as defined in Section 4 below) an &ldquo;ineligible issuer&rdquo; (as defined in Rule 405).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
Registration Statement conformed and will conform in all material respects on the Effective Date, on the date hereof and on the Delivery
Date, and any post-effective amendment to the Registration Statement filed after the date hereof will conform in all material respects
when filed, to the requirements of the Securities Act and the Rules and Regulations. The Company is eligible to use Form S-3 pursuant
to General Instruction I.B.1. of such form, and the Company has met all the conditions for incorporation by reference pursuant to Item
12 and the General Instructions to Form S-3. The most recent Preliminary Prospectus conformed, and the Prospectus will conform when filed
with the Commission pursuant to Rule 424(b) of the Rules and Regulations and on the Delivery Date, in all material respects, to the requirements
of the Securities Act and the Rules and Regulations. The documents incorporated by reference in the Registration Statement, the Preliminary
Prospectus or the Prospectus conformed when filed with the Commission, in all material respects to the requirements of the Exchange Act
or the Securities Act, as applicable, and the Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
Registration Statement does not and did not as of the Effective Date, contain an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein not misleading;&nbsp;<I>provided</I>&nbsp;that
no representation or warranty is made as to information contained in or omitted from the Registration Statement, or any Rule 462(b) Registration
Statement, or any post-effective amendment thereto, made in reliance upon and in conformity with information relating to any Underwriter
furnished to the Company in writing by the Representative on behalf of any Underwriter specifically for inclusion therein, which information
is specified in Section 8(e) (the &ldquo;<B>Underwriter Information</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) The
Prospectus will not, as of its date and on the Delivery Date, contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading;&nbsp;<I>provided</I>&nbsp;that no representation or warranty is made as to information contained in or omitted
from the Prospectus in reliance upon and in conformity with the Underwriter Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) The
documents incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, when they were
filed with the Commission, conformed in all material respects to the requirements of the Exchange Act, and none of such documents contained
any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, when such documents are filed with the Commission, will conform
in all material respects to the requirements of the Exchange Act and will not contain any untrue statement of a material fact or omit
to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) The
Pricing Disclosure Package did not, as of the Applicable Time, contain an untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;&nbsp;<I>provided</I>&nbsp;that
no representation or warranty is made as to information contained in or omitted from the Pricing Disclosure Package in reliance upon
and in conformity with the Underwriter Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) Each
Issuer Free Writing Prospectus (including, without limitation, any road show that is a free writing prospectus under Rule 433), as of
its issue date and at all subsequent times throughout the completion of the public offer and sale of the Securities, when considered
together with the Pricing Disclosure Package as of the Applicable Time, did not contain an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading. No Issuer Free Writing Prospectus conflicts or will conflict with the information contained
in the Registration Statement, Pricing Disclosure Package or the Prospectus, including any document incorporated by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Each
Issuer Free Writing Prospectus conformed or will conform in all material respects to the requirements of the Securities Act and the Rules
and Regulations on the date of first use, and the Company has complied with all prospectus delivery and any filing requirements applicable
to such Issuer Free Writing Prospectus pursuant to the Rules and Regulations. The Company has not made any offer relating to the Securities
that would constitute an Issuer Free Writing Prospectus without the prior written consent of the Representative. The Company has retained
in accordance with the Rules and Regulations all Issuer Free Writing Prospectuses that were not required to be filed pursuant to the
Rules and Regulations. The Company has taken all actions necessary so that any &ldquo;road show&rdquo; (as defined in Rule 433 of the
Rules and Regulations) in connection with the offering of the Securities will not be required to be filed pursuant to the Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) The
Company (i) has not engaged in any Testing-the-Waters Communication other than Testing-the-Waters Communications with the consent of
the Representative with entities that are reasonably believed to be qualified institutional buyers within the meaning of Rule 144A under
the Securities Act or institutions that are accredited investors within the meaning of Rule 501 under the Securities Act and (ii) has
not authorized anyone other than the Representative to engage in Testing-the-Waters Communications. The Company reconfirms that the Representative
has been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The Company has not distributed or approved
for distribution any Written Testing-the-Waters Communications other than those listed on&nbsp;<U>Schedule III</U>&nbsp;hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) Each
Written Testing-the-Waters Communication prepared or approved by the Company in writing, did not, as of the Applicable Time, when taken
together with the Pricing Disclosure Package, contain an untrue statement of a material fact or omit to state a material fact necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading;&nbsp;<I>provided</I>&nbsp;that
no representation or warranty is made as to information contained in or omitted from such Written Testing-the-Waters Communication listed
on&nbsp;<U>Schedule III</U>&nbsp;hereto in reliance upon and in conformity with the Underwriter Information. Each Written Testing-the-Waters
Communications did not, as of the Applicable Time, and at all times through the completion of the public offer and sale of the Securities
will not, include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement,
the Pricing Disclosure Package or the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) Each
of the Company and its subsidiaries (as defined in Section 17) has been duly organized, is validly existing and in good standing as a
corporation or other business entity under the laws of its jurisdiction of organization; each of the Company and its subsidiaries (as
defined in Section 17) is duly qualified to do business and in good standing as a foreign corporation or other business entity in each
jurisdiction in which its ownership or lease of property or the conduct of its businesses requires such qualification, except where the
failure to be so qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a material
adverse effect on (i) the condition (financial or otherwise), results of operations, management, stockholders&rsquo; equity, properties,
business or prospects of the Company and its subsidiaries taken as a whole, (ii) the ability of the Company to consummate the transactions
contemplated hereby or (iii) the ability of the Company to list the Common Stock on, or result in the delisting of the Common Stock from,
The Nasdaq Stock Market (in each case, a &ldquo;<B>Material Adverse Effect</B>&rdquo;); and each of the Company and its subsidiaries
has all power and authority necessary to own or hold its properties and to conduct the businesses in which it is engaged and as disclosed
in the Pricing Disclosure Package.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) The
Company has an authorized capitalization as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
and all of the issued shares of capital stock of the Company have been duly authorized and validly issued, are fully paid and non-assessable,
conform to the description thereof contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and were
issued in compliance with federal and state securities laws and not in violation of any preemptive right, resale right, right of first
refusal or similar right. All of the Company&rsquo;s options, warrants and other rights to purchase or exchange any securities for shares
of the Company&rsquo;s capital stock have been duly authorized and validly issued, conform to the description thereof contained in the
Registration Statement, the Pricing Disclosure Package and the Prospectus and were issued in compliance with federal and state securities
laws. All of the issued shares of capital stock of each subsidiary of the Company have been duly authorized and validly issued, are fully
paid and non-assessable and are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims,
except for such liens, encumbrances, equities or claims as would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) With
respect to the Common Stock purchase options (the &ldquo;<B>Stock Options</B>&rdquo;) granted pursuant to the stock-based compensation
plans of the Company and its subsidiaries (the &ldquo;<B>Company Stock Plans</B>&rdquo;), (i) each Stock Option intended to qualify as
an &ldquo;incentive stock option&rdquo; under Section 422 of the Code so qualifies, (ii) each grant of a Stock Option was duly authorized
no later than the date on which the grant of such Stock Option was by its terms to be effective (the &ldquo;<B>Grant Date</B>&rdquo;)
by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted
and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, and the
award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (iii) each such grant was made in
accordance with the terms of the Company Stock Plans, the Exchange Act and all other applicable laws and regulatory rules or requirements,
including the rules of the Nasdaq Capital Market and any other exchange on which Company securities were traded at the time of such grant,
and (iv) each such grant was properly accounted for in accordance with United States generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;)
in the financial statements (including the related notes) of the Company and disclosed in the Company&rsquo;s filings with the Commission
in accordance with the Exchange Act and all other applicable laws. The Company has not knowingly granted, and there is no and has been
no policy or practice of the Company of granting, Stock Options prior to, or otherwise coordinating the grant of Stock Options with,
the release or other public announcement of material information regarding the Company or its subsidiaries or their results of operations
or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) The
Shares to be issued and sold by the Company to the Underwriters hereunder have been duly authorized and, upon payment and delivery in
accordance with this Agreement, will be validly issued, fully paid and non-assessable, will conform to the description thereof contained
in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will be issued in compliance with federal and state
securities laws and will be free of statutory and contractual preemptive rights, rights of first refusal and similar rights. The Warrant
Shares issuable upon the exercise of the Warrants have been duly authorized and reserved for issuance and, when issued and paid for upon
the due exercise of the Warrants, will be validly issued, fully paid and non-assessable, will be issued in compliance with federal and
state securities laws and will be free of statutory and contractual preemptive rights, rights of first refusal and similar rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) The
Company has all requisite corporate power and authority to execute, deliver and perform its obligations under this Agreement and the
Warrants; and all action required to be taken for the due and proper authorization, execution and delivery of this Agreement and the
Warrants and the consummation by it of the transactions contemplated hereby and thereby has been duly and validly taken. This Agreement
has been duly and validly authorized, executed and delivered by the Company. The Warrants have been duly and validly authorized and,
upon execution and delivery thereof by the Company, will constitute legal, valid and binding obligations of the Company enforceable against
the Company in accordance with their respective terms, except (i) as limited by general equitable principles and applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally,
and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies. This
Agreement conforms, and the Warrants when issued will conform, to the descriptions thereof contained in the Registration Statement, the
Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) The
execution, delivery and performance of this Agreement and the Warrants, the consummation of the transactions contemplated hereby and
the application of the proceeds from the sale of the Securities as described under &ldquo;Use of Proceeds&rdquo; in the Registration
Statement, the Pricing Disclosure Package and the Prospectus will not (i)&nbsp;conflict with or result in a breach or violation of any
of the terms or provisions of, impose any lien, charge or encumbrance upon any property or assets of the Company and its subsidiaries,
or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, license or other agreement or instrument to which
the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the
property or assets of the Company or any of its subsidiaries is subject; (ii)&nbsp;result in any violation of the provisions of the charter
or by-laws (or similar organizational documents) of the Company or any of its subsidiaries; or (iii)&nbsp;result in any violation of
any statute or any judgment, order, decree, rule or regulation of any court or governmental agency or body, domestic or foreign, having
jurisdiction over the Company or any of its subsidiaries or any of their properties or assets, except, with respect to clauses (i) and
(iii), for such conflicts, breaches, violations, liens, charges, encumbrances or defaults that would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) No
consent, approval, authorization or order of, or filing, registration or qualification with, any person (including any court or governmental
agency or body having jurisdiction over the Company or any of its subsidiaries or any of their properties or assets) is required to be
obtained by the Company for the execution, delivery and performance of this Agreement or the Warrants, the consummation of the transactions
contemplated hereby and the application of the proceeds from the sale of the Securities as described under &ldquo;Use of Proceeds&rdquo;
in the Registration Statement, the Pricing Disclosure Package and the Prospectus, except for the registration of the Securities under
the Securities Act and such consents, approvals, authorizations, orders, filings, registrations or qualifications as may be required
under the Exchange Act, the rules and regulations of the Financial Industry Regulatory Authority, Inc. (&ldquo;<B>FINRA</B>&rdquo;) and
applicable state or foreign securities laws in connection with the purchase and sale of the Securities by the Underwriters and such consents,
approvals, authorizations, orders, filings, registrations or qualifications, which, if not obtained, would not, individually or in the
aggregate, reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) Except
as disclosed in the Pricing Disclosure Package and the Prospectus, there are no contracts, agreements or understandings between the Company
and any person granting such person the right to require the Company to file a registration statement under the Securities Act with respect
to any securities of the Company owned or to be owned by such person or to require the Company to include such securities in the securities
registered pursuant to the Registration Statement or in any securities being registered pursuant to any other registration statement
filed by the Company under the Securities Act; no person has the right to act as an underwriter or as a financial advisor to the Company
in connection with the offer and sale of the Securities other than the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) The
Company has not sold or issued any securities that would be integrated with the offering of the Securities contemplated by this Agreement
pursuant to the Securities Act, the Rules and Regulations or the interpretations thereof by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) Neither
the Company nor any of its subsidiaries has sustained, since the date of the latest audited financial statements included or incorporated
by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, any loss or interference with its business
from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental
action, order or decree, and since such date, there has not been any change in the capital stock or long-term debt of the Company or
any of its subsidiaries or any adverse change, or any development or event involving a prospective change, in or affecting the condition
(financial or otherwise), results of operations, stockholders&rsquo; equity, properties, management, business or prospects of the Company
and its subsidiaries taken as a whole, in each case except as would not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect. Since the date as of which information is given in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, the Company has not (i)&nbsp;incurred any liability or obligation, direct or contingent, other than liabilities
and obligations that were incurred in the ordinary course of business, (ii) entered into any material transaction not in the ordinary
course of business, (iii) declared or paid any dividend on its capital stock or (iv) purchased any of its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) The
historical financial statements (including the related notes and supporting schedules) included or incorporated by reference in the Registration
Statement, the Pricing Disclosure Package and the Prospectus comply as to form in all material respects with the requirements of Regulation
S-X under the Securities Act and present fairly the financial condition, results of operations and cash flows of the entities purported
to be shown thereby at the dates and for the periods indicated and have been prepared in conformity with GAAP applied on a consistent
basis throughout the periods involved and the schedules included or incorporated by reference in the Registration Statement, the Pricing
Disclosure Package and the Prospectus present fairly the information required to be stated therein. The selected financial data and the
summary financial information included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and
the Prospectus present fairly the information shown therein and have been complied on a basis consistent with that of the audited financial
statements included or incorporated by reference therein. Except as included therein, no historical or pro forma financial statements
or supporting schedules are required to be included or incorporated by reference in the Registration Statement, the Pricing Disclosure
Package or the Prospectus under the Securities Act, the Exchange Act and the Rules and Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) Turner,
Stone &amp; Company, L.L.P., who have certified certain financial statements of the Company and its consolidated subsidiaries, whose
reports are incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus and who have delivered
the initial letter referred to in Section 7(h) hereof, are independent public accountants with respect to the Company and its subsidiaries
within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States)
and as required by the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) The
statements in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the captions &ldquo;Certain Relationships
and Related Transactions, and Director Independence,&rdquo; &ldquo;Description of Capital Stock,&rdquo; and &ldquo;Business&mdash;Our
Intellectual Property,&rdquo; insofar as such statements summarize legal matters, agreements, documents or proceedings discussed therein,
are accurate and fair summaries of such legal matters, agreements, documents or proceedings and present the information required to be
shown.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) The
Company and each of its subsidiaries have good and marketable title in fee simple to all real property and good and marketable title
to all personal property owned by them, in each case free and clear of all liens, encumbrances and defects, except such as are described
in the Registration Statement, the Pricing Disclosure Package and the Prospectus or such as do not materially affect the value of such
property and do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries;
and all assets held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with
no terms or provisions that would materially interfere with the use made or to be made by such assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) The
Company and each of its subsidiaries carry, or are covered by, insurance from insurers of recognized financial responsibility in such
amounts and covering such risks as is adequate for the conduct of their respective businesses and the value of their respective properties
and as is customary for companies engaged in similar businesses in similar industries. All policies of insurance of the Company and its
subsidiaries are in full force and effect; the Company and its subsidiaries are in compliance with the terms of such policies in all
material respects; and neither the Company nor any of its subsidiaries has received notice from any insurer or agent of such insurer
that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance; there are no
claims by the Company or any of its subsidiaries under any such policy or instrument as to which any insurance company is denying liability
or defending under a reservation of rights clause; and neither the Company nor any such subsidiary has any reason to believe that it
will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) Except
as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has not sold or issued any
securities during the six-month period preceding the date of the Prospectus, including but not limited to any sales pursuant to Rule
144A or Regulation D or S of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) Any
statistical and market-related data in the Registration Statement, the Pricing Disclosure Package and the Prospectus and the consolidated
financial statements of the Company and its subsidiaries included in the Registration Statement, the Pricing Disclosure Package or the
Prospectus are based on or derived from sources that the Company believes to be reliable and accurate and, to the extent required, the
Company has obtained the written consent to the use of such data from such sources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) The
Company is not, and as of the Delivery Date and, after giving effect to the offer and sale of the Securities and the application of the
net proceeds therefrom as described under &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, will not be required to register as, (i) an &ldquo;investment company&rdquo; or an entity &ldquo;controlled&rdquo;
by an &ldquo;investment company&rdquo; within the meaning of such term under the Investment Company Act of 1940, as amended (the &ldquo;<B>Investment
Company Act</B>&rdquo;), and the Rules and Regulations or (ii) a &ldquo;business development company&rdquo; (as defined in Section 2(a)(48)
of the Investment Company Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) There
are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (&ldquo;<B>Actions</B>&rdquo;)
pending to which the Company or any of its subsidiaries is or may be a party or to which any property or assets of the Company or any
of its subsidiaries is or may be the subject that, individually or in the aggregate, would reasonably be expected to have a Material
Adverse Effect; no such Actions are threatened or, to the Company&rsquo;s knowledge, contemplated by any governmental or regulatory authority
or threatened by others; and (i) there are no current or pending Actions that are required under the Securities Act to be described in
the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus and (ii) there are no statutes, regulations or contracts or other documents that are
required under the Securities Act to be filed as exhibits to the Registration Statement or described under the Registration Statement,
the Pricing Disclosure Package or the Prospectus that are not so filed as exhibits to the Registration Statement or described in the
Registration Statement, the Pricing Disclosure Package and the Prospectus. Neither the Company nor any of its subsidiaries has knowledge
that any other party to any such contract, agreement or arrangement has any intention not to render full performance as contemplated
by the terms thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) No
relationship, direct or indirect, or related-party transaction exists between or among the Company or any of its subsidiaries, on the
one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company, on the other hand, that
is required by the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package and the Prospectus that
is not so described in or incorporated by reference into such documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff) There
are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees of
indebtedness by the Company to or for the benefit of any of the officers or directors of the Company or any of their respective family
members. The Company has not, directly or indirectly, including through its subsidiaries, extended or maintained credit, arranged for
the extension of credit, or renewed an extension of credit, in the form of a personal loan to or for any director or executive officer
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg) No
labor disturbance by the employees of the Company or its subsidiaries exists or, to the knowledge of the Company, is imminent that could
reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh) (i)
Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (&ldquo;<B>ERISA</B>&rdquo;),
for which the Company or any member of its &ldquo;Controlled Group&rdquo; (defined as any entity, whether or not incorporated, that is
under common control with the Company within the meaning of Section 4001(a)(14) of ERISA or any entity that would be regarded as a single
employer with the Company under Section 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;))
would have any liability (each, a &ldquo;<B>Plan</B>&rdquo;) has been maintained in compliance in all material respects with its terms
and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; (ii)
no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan,
excluding transactions effected pursuant to a statutory or administrative exemption; (iii) for each Plan that is subject to the funding
rules of Section 412 of the Code or Section 302 of ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail,
to satisfy the minimum funding standards (within the meaning of Section 302 of ERISA or Section 412 of the Code) applicable to such Plan;
(iv) no Plan is, or is reasonably expected to be, in &ldquo;at risk status&rdquo; (within the meaning of Section 303(i) of ERISA) and
no Plan that is a &ldquo;multiemployer plan&rdquo; within the meaning of Section 4001(a)(3) of ERISA is in &ldquo;endangered status&rdquo;
or &ldquo;critical status&rdquo; (within the meaning of Sections 304 and 305 of ERISA) (v) the fair market value of the assets of each
Plan exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan);
(vi) no &ldquo;reportable event&rdquo; (within the meaning of Section 4043(c) of ERISA and the regulations promulgated thereunder) has
occurred or is reasonably expected to occur; (vii) each Plan that is intended to be qualified under Section 401(a) of the Code is so
qualified, and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification; (viii)
neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV
of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guarantee Corporation, in the ordinary course and without
default) in respect of a Plan (including a &ldquo;multiemployer plan&rdquo; within the meaning of Section 4001(a)(3) of ERISA); and (ix)
none of the following events has occurred or is reasonably likely to occur: (A) a material increase in the aggregate amount of contributions
required to be made to all Plans by the Company or its Controlled Group affiliates in the current fiscal year of the Company and its
Controlled Group affiliates compared to the amount of such contributions made in the Company&rsquo;s and its Controlled Group affiliates&rsquo;
most recently completed fiscal year; or (B) a material increase in the Company and its subsidiaries&rsquo; &ldquo;accumulated post-retirement
benefit obligations&rdquo; (within the meaning of Accounting Standards Codification Topic 715-60) compared to the amount of such obligations
in the Company and its subsidiaries&rsquo; most recently completed fiscal year, except in each case with respect to the events or conditions
set forth in (i) through (ix) hereof, as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
Company and each of its subsidiaries have filed all federal, state, local and foreign income and franchise tax returns required to be
filed through the date hereof, subject to permitted extensions, and have paid all taxes due thereon, and no tax deficiency has been determined
adversely to the Company or any of its subsidiaries, nor does the Company have any knowledge of any tax deficiencies that could, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj) There
are no transfer taxes or other similar fees or charges under Federal law or the laws of any state, or any political subdivision thereof,
required to be paid in connection with the execution and delivery of this Agreement or the issuance by the Company or sale by the Company
of the Securities or the issuance of the Warrant Shares upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk) Neither
the Company nor any of its subsidiaries (i) is in violation of its charter or by-laws (or similar organizational documents), (ii) is
in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance
or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement, license or other
agreement or instrument to which it is a party or by which it is bound or to which any of its properties or assets is subject or (iii)
is in violation of any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over
it or its property or assets or has failed to obtain any license, permit, certificate, franchise or other governmental authorization
or permit necessary to the ownership of its property or to the conduct of its business, except in the case of clauses (ii) and (iii),
to the extent any such conflict, breach, violation, failure or default would not, individually or in the aggregate, have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll) Except
as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company and each of its subsidiaries
(i) make and keep accurate books and records and (ii) maintain and has maintained effective internal control over financial reporting
as defined in Rule 13a-15 under the Exchange Act and a system of internal accounting controls sufficient to provide reasonable assurance
that (A)&nbsp;transactions are executed in accordance with management&rsquo;s general or specific authorization, (B) transactions are
recorded as necessary to permit preparation of the Company&rsquo;s financial statements in conformity with GAAP and to maintain accountability
for its assets, (C) access to the Company&rsquo;s assets is permitted only in accordance with management&rsquo;s general or specific
authorization, (D) the recorded accountability for the Company&rsquo;s assets is compared with existing assets at reasonable intervals
and appropriate action is taken with respect to any differences and (E) interactive data in eXtensible Business Reporting Language included
or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Pricing Disclosure Package fairly
presents the information called for in all material respects and is prepared in accordance with the Commission&rsquo;s rules and guidelines
applicable thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm) Except
as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (i) the Company and each of its subsidiaries
have established and maintain disclosure controls and procedures (as such term is defined in Rule 13a-15 under the Exchange Act), (ii)
such disclosure controls and procedures are designed to ensure that the information required to be disclosed by the Company and its subsidiaries
in the reports they will file or submit under the Exchange Act is accumulated and communicated to management of the Company and its subsidiaries,
including their respective principal executive officers and principal financial officers, as appropriate, to allow timely decisions regarding
required disclosure to be made and (iii) such disclosure controls and procedures are effective in all material respects to perform the
functions for which they were established. The Company and its subsidiaries have carried out evaluations of the effectiveness of their
disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn) Except
as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, since the date of the most recent balance
sheet of the Company and its consolidated subsidiaries reviewed or audited by Turner, Stone &amp; Company, L.L.P. and the audit committee
of the board of directors of the Company, (i) the Company has not been advised of (A)&nbsp;any significant deficiencies in the design
or operation of internal controls that could adversely affect the ability of the Company and each of its subsidiaries to record, process,
summarize and report financial data, or any material weaknesses in internal controls and (B) any fraud, whether or not material, that
involves management or other employees who have a significant role in the internal controls of the Company and each of its subsidiaries,
and (ii) since that date, there have been no significant changes in internal controls or in other factors that could significantly affect
internal controls, including any corrective actions with regard to significant deficiencies and material weaknesses. Neither the Company
nor its Audit Committee is reviewing or investigating, and neither the Company&rsquo;s independent auditors nor its internal auditors
have recommended that the Company or its Audit Committee review or investigate (1) adding to, deleting, changing the application of,
or changing the Company&rsquo;s disclosure with respect to, any of the Company&rsquo;s material accounting policies, or (2) any matter
which could result in a restatement of the Company&rsquo;s financial statements for any annual or interim period during the current or
prior three fiscal years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo) There
is and has been no failure on the part of the Company and, to the knowledge of the Company, any of the Company&rsquo;s directors or officers,
in their capacities as such, to comply with the applicable provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp) Except
as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no off-balance sheet arrangements,
outstanding guarantees or other contingent obligations of the Company. All disclosures contained in the Registration Statement, the Pricing
Disclosure Package and the Prospectus of &ldquo;non-GAAP financial measures&rdquo; (as such term is defined by the rules and regulations
promulgated by the Commission) comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to
the extent applicable</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq) The
section captioned &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations &ndash; Critical
Accounting Policies <FONT STYLE="background-color: white">and Significant Judgments and Estimates</FONT>&rdquo; in the Registration Statement,
the Pricing Disclosure Package and the Prospectus accurately and fully describes (A) the accounting policies that the Company believes
are the most important in the portrayal of the Company&rsquo;s financial condition and results of operations and that require management&rsquo;s
most difficult, subjective or complex judgments (&ldquo;<B>Critical Accounting Policies</B>&rdquo;);<B>&nbsp;</B>(B) the judgments and
uncertainties affecting the application of Critical Accounting Policies; and (C) the likelihood that materially different amounts would
be reported under different conditions or using different assumptions and an explanation thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr) The
Company and each of its subsidiaries have and are in compliance with such permits, licenses, patents, franchises, certificates of need
and other approvals or authorizations of governmental or regulatory authorities (&ldquo;<B>Permits</B>&rdquo;), as are necessary under
applicable law to own their properties and conduct their businesses in the manner described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, except for any of the foregoing that could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect; each of the Company and its subsidiaries has fulfilled and performed all of its obligations
with respect to the Permits, and no event has occurred that allows, or after notice or lapse of time would allow, revocation or termination
thereof or results in any other impairment of the rights of the holder or any such Permits, except for any of the foregoing that could
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries
has received notice of any revocation or modification of any Permits that would, individually or in the aggregate, reasonably be expected
to result in a Material Adverse Effect or has any reason to believe that any such Permits will not be renewed in the ordinary course.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
The Company and each of its subsidiaries owns, possesses, or has rights to use, all Intellectual Property necessary for the conduct of
the Company&rsquo;s and its subsidiaries&rsquo; business as described in the Registration Statement, and there are no unreleased liens
or security interests which have been filed, or which the Company has received notice of, against any of the patents owned by the Company.
Furthermore, (A) to the Company&rsquo;s knowledge, there is no infringement, misappropriation or violation by third parties of any such
Intellectual Property, except as such infringement, misappropriation or violation would not result in a Material Adverse Effect; (B)
there is no pending or, to the Company&rsquo;s knowledge, threatened, Action by others challenging the Company&rsquo;s or any of its
subsidiaries&rsquo; rights in or to any such Intellectual Property, and to the Company&rsquo;s knowledge, there are no facts which would
form a reasonable basis for any such Action; (C) the Intellectual Property owned by the Company and its subsidiaries, and to the Company&rsquo;s
knowledge, the Intellectual Property licensed to the Company and its subsidiaries, has not been adjudged invalid or unenforceable, in
whole or in part, and there is no pending or, to the Company&rsquo;s knowledge, threatened Action by others challenging the validity,
enforceability or scope of any such Intellectual Property, and, to the Company&rsquo;s knowledge, there are no facts which would form
a reasonable basis for any such Action; (D) there is no pending or, to the Company&rsquo;s knowledge, threatened Action by others that
the Company or any of its subsidiaries infringes, misappropriates or otherwise violates any Intellectual Property or other proprietary
rights of others, neither the Company nor any of its subsidiaries has received any written notice of such Action, and, to the Company&rsquo;s
knowledge, there are no other facts which would form a reasonable basis for any such Action, except in each case for any Action as would
not be reasonably expected to have a Material Adverse Effect; and (E) to the Company&rsquo;s knowledge, no employee of the Company or
any of its subsidiaries is in violation of any term of any employment contract, patent disclosure agreement, invention assignment agreement,
non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer
where the basis of such violation relates to such employee&rsquo;s employment with the Company or any of its subsidiaries or actions
undertaken by the employee while employed with the Company or any of its subsidiaries, except such violation as would not reasonably
be expected to have a Material Adverse Effect. Except as would not reasonably be expected to have a Material Adverse Effect, (1) the
Company and its subsidiaries have disclosed to the U.S. Patent and Trademark Office (USPTO) all information known to the Company to be
relevant to the patentability of its inventions in accordance with 37 C.F.R. Section 1.56, and (2) neither the Company nor any of its
subsidiaries made any misrepresentation or concealed any information from the USPTO in any of the patents or patent applications owned
or licensed to the Company, or in connection with the prosecution thereof, in violation of 37 C.F.R. Section 1.56. Except as would not
reasonably be expected to have a Material Adverse Effect and to the Company&rsquo;s knowledge, (x) there are no facts that are reasonably
likely to provide a basis for a finding that the Company or any of its subsidiaries does not have clear title to the patents or patent
applications owned or licensed to the Company or other proprietary information rights as being owned by the Company or any of its subsidiaries,
(y) no valid issued U.S. patent would be infringed by the activities of the Company or any of its subsidiaries relating to products currently
or proposed to be manufactured, used or sold by the Company or any of its subsidiaries and (z) there are no facts with respect to any
issued patent owned that would cause any claim of any such patent not to be valid and enforceable with applicable regulations. &ldquo;<U>Intellectual
Property</U>&rdquo; shall mean all patents, patent applications, trade and service marks, trade and service mark registrations, trade
names, copyrights, licenses, inventions, trade secrets, domain names, technology and know-how.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt) &nbsp;The
Company and each of its subsidiaries (i) are, and at all times prior hereto were, in compliance with all laws, regulations, ordinances,
rules, orders, judgments, decrees, permits or other legal requirements of any governmental authority, including without limitation any
international, national, state, provincial, regional, or local authority, relating to the protection of human health or safety, the environment,
or natural resources, or to hazardous or toxic substances or wastes, pollutants or contaminants (&ldquo;<B>Environmental Laws</B>&rdquo;)
applicable to such entity, which compliance includes, without limitation, obtaining, maintaining and complying with all permits and authorizations
and approvals required by Environmental Laws to conduct their respective businesses, and (ii)&nbsp;have not received notice of any actual
or alleged violation of Environmental Laws, or of any potential liability for or other obligation concerning the presence, disposal or
release of hazardous or toxic substances or wastes, pollutants or contaminants, except in the case of clause (i) or (ii) where such non-compliance,
violation, liability or other obligation would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (A) there are no proceedings
that are pending, or known to be contemplated, against the Company or any of its subsidiaries under Environmental Laws in which a governmental
authority is also a party, other than such proceedings regarding which it is reasonably believed no monetary sanctions of $100,000 or
more will be imposed, (B) the Company and its subsidiaries are not aware of any issues regarding compliance with Environmental Laws,
or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants,
that would reasonably be expected to have a Material Adverse Effect and (C) none of the Company and its subsidiaries anticipates material
capital expenditures relating to Environmental Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu) Neither
the Company nor any subsidiary is in violation of or has received notice of any violation with respect to any federal or state law relating
to discrimination in the hiring, promotion or pay of employees, nor any applicable federal or state wage and hour laws, nor any state
law precluding the denial of credit due to the neighborhood in which a property is situated, the violation of any of which would reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv) No
subsidiary of the Company is currently prohibited, directly or indirectly, from paying any dividends to the Company, from making any
other distribution on such subsidiary&rsquo;s capital stock, from repaying to the Company any loans or advances to such subsidiary from
the Company or from transferring any of such subsidiary&rsquo;s property or assets to the Company or any other subsidiary of the Company,
except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ww) Neither
the Company nor any of its subsidiaries nor, to the Company&rsquo;s best knowledge, any director, officer, agent, employee or other person
associated with or acting on behalf of the Company or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution,
gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise
or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including
of any government-owned or controlled entity or of a public international organization or any person acting in an official capacity for
or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is
in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act of 2010, as amended, any
applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business
Transactions or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in
furtherance of any bribe, rebate, payoff, influence payment, kickback or other unlawful payment. The Company and its subsidiaries have
instituted, maintain and enforce policies and procedures designed to promote and ensure compliance with the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx) The
operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot Act, the money
laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines,
issued, administered or enforced by any governmental agency (collectively, the &ldquo;<B>Money Laundering Laws</B>&rdquo;) and no action,
suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of
its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(yy) None
of the Company, its subsidiaries or, to the Company&rsquo;s best knowledge, any of their respective directors or officers or, to the
knowledge of the Company, any agent (while acting in such capacity), employee or other person acting on behalf of the Company or its
subsidiaries is (i) currently subject to or the target of any sanctions administered or enforced by the Office of Foreign Assets Control
of the U.S. Treasury Department (&ldquo;<B>OFAC</B>&rdquo;), the U.S. Department of State, the United Nations Security Council (&ldquo;<B>UNSC</B>&rdquo;),
the European Union (&ldquo;<B>EU</B>&rdquo;), Her Majesty&rsquo;s Treasury (&ldquo;<B>HMT</B>&rdquo;), or other relevant sanctions authority
(collectively, &ldquo;<B>Sanctions</B>&rdquo;); (ii) located, organized or resident in a country that is the subject of Sanctions (including,
without limitation, Cuba, Iran, North Korea and Syria); or (iii) on the Specially Designated Nationals List (the &ldquo;<B>SDNL</B>&rdquo;)
of the U.S. Treasury Department; and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute
or otherwise make available such proceeds to its subsidiaries, joint venture partner or other person or entity, (i) to fund or facilitate
any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions
or that appears on the SDNL, (ii) to fund or facilitate any activities of or business in any country that is the subject or target of
Sanctions or that appears on the SDNL or (iii) in any other manner that will result in a violation by any person (including any person
participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions. The Company and its subsidiaries
have not knowingly engaged in for the past five years, are not now knowingly engaged in, and will not knowingly engage in, any dealings
or transactions with any individual or entity, or in any country or territory, that at the time of the dealing or transaction is or was
the subject or target of Sanctions or currently appears on the SDNL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(zz) The
Company and its subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks, hardware, software, websites,
applications, and databases (collectively, &ldquo;<B>IT Systems</B>&rdquo;) are adequate for, and operate and perform in all material
respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, and
are, to the Company&rsquo;s knowledge, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other
corruptants. The Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures,
and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and
security of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated data (&ldquo;<B>Personal
Data</B>&rdquo;)) used in connection with their businesses, and there have been no breaches, violations, outages or unauthorized uses
of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other person,
nor any incidents under internal review or investigations relating to the same. The Company and its subsidiaries are presently in material
compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental
or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal
Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification. The
Company and its subsidiaries have taken all necessary actions to prepare to comply with the European Union General Data Protection Regulation
(and all other applicable laws and regulations with respect to Personal Data that have been announced as of the date hereof as becoming
effective within twelve (12) months after the date hereof, and for which any non-compliance with same would be reasonably likely to create
a material liability) as soon they take effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aaa) The
Company has not distributed and, prior to the later to occur of the Delivery Date and completion of the distribution of the Securities,
will not distribute any offering material in connection with the offering and sale of the Securities other than any Preliminary Prospectus,
the Prospectus, any Issuer Free Writing Prospectus to which the Representative has consented in accordance with Section 1(i) or 5(a)(v).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bbb) The
Company has obtained for the benefit of the underwriters the Lock-Up Agreements referred to in Section 5(a)(ix) hereof from each of its
&ldquo;directors&rdquo; and &ldquo;officers&rdquo; (within the meaning of Rule 16a-1(f) under the Exchange Act) and each shareholder
of the Company set forth on&nbsp;<U>Schedule V</U>&nbsp;hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ccc) None
of the Company, its officers or its directors has taken and will not take, directly or indirectly, any action designed to or that has
constituted or that could reasonably be expected to cause or result in the stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ddd) There
are no contracts, agreements or understandings between the Company and any person (other than the Underwriters) that would give rise
to a valid claim against the Company or any Underwriter for a brokerage commission, finder&rsquo;s fee or other like payment in connection
with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(eee) The
Common Stock is listed on The NASDAQ Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(fff)
Neither the issuance, sale and delivery of the Securities nor the application of the proceeds thereof by the Company as described in
each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board
of Governors of the Federal Reserve System or any other regulation of such Board of Governors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ggg) No
forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) included or incorporated
by reference in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed without
a reasonable basis or has been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
certificate signed by any officer of the Company and delivered to the Representative or counsel for the Underwriters in connection with
the offering of the Securities shall be deemed a representation and warranty by the Company, as to matters covered thereby, to each Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <I>Purchase
of the Securities by the Underwriters.</I> On the basis of the representations and warranties contained in, and subject
to the terms and conditions of, this Agreement, the Company agrees to sell to the several Underwriters, and each of the Underwriters,
severally and not jointly, agrees to purchase, the number of Shares and/or Pre-Funded Warrants set forth opposite that Underwriter&rsquo;s
name in&nbsp;<U>Schedule I</U>&nbsp;hereto, provided that to the extent any Underwriter sells fewer Shares or Pre-Funded Warrants and
therefore determines to purchase fewer Shares or Pre-Funded Warrants, such amount shall be reduced on a pro rata basis based on the number
of Shares or Pre-Funded Warrants actually purchased. The Underwriters shall notify the Company of the number of Shares and/or Pre-Funded
Warrants they intend to purchase at the Delivery Date on the business day preceding the Delivery Date, provided that such notification
shall not be binding upon the Underwriters. The respective purchase obligations of the Underwriters with respect to the Shares and/or
Pre-Funded Warrants shall be rounded among the Underwriters to avoid fractional shares, as the Representative may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price of the Shares purchased by the Underwriters shall be $2.76 (92.0% of the public offering price) (or, in the case of Shares resold
by the Underwriters or their selected dealers to persons named in <U>Schedule IV</U> hereto $2.88 (96.0% of the public offering price)
per Share. The price of the Pre-Funded Warrants purchased by the Underwriters shall be $2.7599 (or, in the case of Pre-Funded Warrants
resold by the Underwriters or their selected dealers to persons named in <U>Schedule IV</U> hereto $2.8777 per Pre-Funded Warrant Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall not be obligated to deliver any of the Shares to be delivered on the Delivery Date, except upon payment for all Shares
to be purchased on the Delivery Date as provided herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is strictly a &ldquo;best efforts&rdquo; offering. It is understood between the parties that there is no firm commitment by the Underwriters
to purchase any or all of the Securities. It is also understood and agreed that the Underwriters shall not and are under no obligation
to purchase any Securities for their own account and that this Agreement does not create any partnership, joint venture, or other similar
relationship between or among the Underwriters and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <I>Offering
of Stock by the Underwriters</I>. Upon authorization by the Representative of the release of the Securities, the several Underwriters
propose to offer the Securities for sale upon the terms and conditions to be set forth in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <I>Delivery
of and Payment for the Securities.</I>&nbsp;Delivery of and payment for the Securities shall be made at 10:00&nbsp;A.M., New York City
time, on the first full business day following the date of this Agreement or at such other date or place as shall be determined by agreement
between the Representative and the Company. This date and time are sometimes referred to as the &ldquo;<B>Delivery Date</B>.&rdquo; Delivery
of the Securities shall be made to the Representative for the account of each Underwriter against payment by the several Underwriters
through the Representative and of the respective aggregate purchase prices of the Securities being sold by the Company to or upon the
order of the Company of the purchase price by wire transfer in immediately available funds to the accounts specified by the Company.
Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further condition of the obligation
of each Underwriter hereunder. The Company shall (a) deliver, or cause to be delivered, the Shares on the Delivery Date through the facilities
of DTC unless the Representative shall otherwise instruct and (b)&#8239;deliver, or cause to be delivered, to the Underwriters &#8239;the
Pre-Funded Warrants on the Delivery Date in definitive form, in accordance with the Representative&rsquo;s instructions, issued in such
names and in such denominations as the Representative may direct by notice in writing to the Company given prior to the Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, the Company and the Representative may instruct purchasers of the Pre-Funded Warrants to make payment for the Pre-Funded
Warrants on the Delivery Date to the Company, at the public offering price per Pre-Funded Warrant set forth on Schedule II hereto, by
wire transfer in immediately available funds to the account specified by the Company in lieu of payment by the Underwriters for such
Pre-Funded Warrants, and the Company shall deliver such Pre-Funded Warrants to such purchasers on the Delivery Date in definitive form
against such payment, in lieu of the Company&rsquo;s obligation to deliver such Pre-Funded Warrants to the Underwriters; provided that
the underwriting discounts and commissions in respect of the Pre-Funded Warrants, as calculated by subtracting the purchase price per
Pre-Funded Warrant payable by the Underwriters as set forth in Section&#8239;2 from the public offering price per Pre-Funded Warrant
set forth on Schedule II hereto, shall be deducted and withheld from the amount otherwise payable by the Underwriters to the Company
for the Shares as set forth in Section&#8239;2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that any purchaser of the Pre-Funded Warrants instructed to make payment to the Company for all or part of the Pre-Funded Warrants
fails to do so on the Delivery Date, the Underwriters shall either (i)&#8239;make payment to the Company for such Pre-Funded Warrants
at the purchase price specified in Section&#8239;2, or (ii)&#8239;elect, by written notice to the Company, to receive shares of Common
Stock at the purchase price specified in Section&#8239;2 in lieu of all or a portion of such Pre-Funded Warrants contemplated to be sold
under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <I>Further
Agreements of the Company and the Underwriters</I>. (a) The Company agrees:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) To
prepare the Prospectus in a form approved by the Representative and to file such Prospectus pursuant to Rule 424(b) and Rule 430A, 430B
and 430C under the Securities Act, as applicable, not later than the Commission&rsquo;s close of business on the second business day
following the execution and delivery of this Agreement and to provide satisfactory evidence to the Representative of such timely filing;
to file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission
pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery
of a prospectus is required in connection with the offering or sale of the Securities; to make no further amendment or any supplement
to the Registration Statement or the Prospectus prior to the Delivery Date except, with the prior written consent of the Representative
or as provided herein, which consent shall not be unreasonably withheld, conditioned or delayed; to advise the Representative, promptly
after it receives notice thereof, of the time when any amendment or supplement to the Registration Statement or the Prospectus has been
filed and to furnish the Representative with copies thereof to the extent reasonably requested; to advise the Representative, promptly
after it receives notice thereof, of the issuance by the Commission of any stop order or of any order preventing or suspending the use
of the Prospectus or any Issuer Free Writing Prospectus, of the suspension of the qualification of the Securities for offering or sale
in any jurisdiction, of the initiation or threatening of any proceeding or examination for any such purpose or of any request by the
Commission for the amending or supplementing of the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus or for
additional information; and, in the event of the issuance of any stop order or of any order preventing or suspending the use of the Prospectus
or any Issuer Free Writing Prospectus or suspending any such qualification, to use promptly its best efforts to obtain its withdrawal;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) To
deliver promptly to the Representative such number of the following documents as the Representative shall reasonably request: (A) conformed
copies of the Registration Statement as originally filed with the Commission and each amendment thereto (in each case including exhibits
and consents filed therewith and documents incorporated by reference therein), (B) each Preliminary Prospectus, the Prospectus and any
amended or supplemented Prospectus, (C) each Issuer Free Writing Prospectus and (D) any document incorporated by reference in any Preliminary
Prospectus or the Prospectus (unless available on EDGAR); and, if the delivery of a prospectus is required at any time after the date
hereof in connection with the offering or sale of the Securities or any other securities relating thereto and if at such time any events
shall have occurred as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which
they were made when such Prospectus is delivered, not misleading, or, if for any other reason it shall be necessary to amend or supplement
the Prospectus in order to comply with the Securities Act, to notify the Representative and, upon its request, to prepare and file such
document and to prepare and furnish without charge to each Underwriter and to any dealer in securities as many copies as the Representative
may from time to time reasonably request of an amended or supplemented Prospectus that will correct such statement or omission or effect
such compliance;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) To
file promptly with the Commission any amendment or supplement to the Registration Statement or the Prospectus that may, in the reasonable
judgment of the Company or the Representative, be required by the Securities Act or requested by the Commission in connection with the
offering of the Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) During
the period when a prospectus relating to the Securities is required by the Securities Act to be delivered, prior to filing with the Commission
any amendment or supplement to the Registration Statement, the Prospectus, any document incorporated by reference in the Prospectus or
any amendment to any document incorporated by reference in the Prospectus, to furnish a copy thereof to the Representative and counsel
for the Underwriters and obtain the consent of the Representative to the filing. Neither the Representative&rsquo;s consent to, nor the
Underwriters&rsquo; delivery of, any such amendment or supplement shall constitute a waiver of any of the conditions set forth in Section&nbsp;7
hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) Not
to make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus without the prior written consent
of the Representative;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) To
comply with all applicable requirements of Rule 433 with respect to any Issuer Free Writing Prospectus with respect to the Securities;
and if at any time after the date hereof any events shall have occurred as a result of which any Issuer Free Writing Prospectus, as then
amended or supplemented, would conflict with the information in the Registration Statement, the Pricing Disclosure Package or the Prospectus
or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading, or, if for any other reason it shall be necessary
to amend or supplement any Issuer Free Writing Prospectus, to notify the Representative and, upon its request, to file such document
and to prepare and furnish without charge to each Underwriter as many copies as the Representative may from time to time reasonably request
of an amended or supplemented Issuer Free Writing Prospectus that will correct such conflict, statement or omission or effect such compliance;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) As
soon as practicable, but not later than twelve (12) months after the date of this Agreement, to make generally available to its security
holders an earning statement (which need not be audited) covering a period of at least twelve (12) months beginning with the first fiscal
quarter of the Company occurring after the date of this Agreement, which will satisfy the provisions of Section 11(a) of the Securities
Act and Rule 158 of the Securities Act;&nbsp;<I>provided</I>&nbsp;that this obligation shall be deemed satisfied if the Company shall
have filed the requisite reports with the Commission containing such information;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii) &nbsp;Promptly
from time to time to take such action as the Representative may reasonably request to qualify the Securities for offering and sale under
the securities laws of such jurisdictions as the Representative may reasonably request and to comply with such laws so as to permit the
continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to complete the distribution of the Securities;&nbsp;<I>provided</I>&nbsp;that
in connection therewith the Company shall not be required to (i) qualify as a foreign corporation in any jurisdiction in which it would
not otherwise be required to so qualify, (ii) file a general consent to service of process in any such jurisdiction or (iii) subject
itself to taxation in any jurisdiction in which it would not otherwise be subject;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix) For
a period commencing on the date hereof and ending on the 30th day after the Delivery Date (the &ldquo;<B>Lock-Up Period</B>&rdquo;),
except for the Securities to be sold hereunder, not to, directly or indirectly, (1) offer for sale, sell, issue, contract to sell, pledge
or otherwise dispose of, directly or indirectly (or enter into any transaction or device that is designed to, or could be expected to,
result in the disposition by any person at any time in the future of) any shares of Common Stock or other equity securities of the Company
(or securities of the Company convertible into or exercisable or exchangeable for Common Stock or other equity securities of the Company)
(collectively, &ldquo;<B>Lock-Up Securities</B>&rdquo;), or sell or grant options, rights or warrants with respect to any Lock-Up Securities
(other than the grant of options or other equity awards in the ordinary course of business pursuant to incentive plans described in the
Registration Statement), (2) enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any
of the economic benefits or risks of ownership of shares of Common Stock, whether any such transaction described in clause (1) or (2)
above is to be settled by delivery of Common Stock or other securities, in cash or otherwise, (3) offer to purchase, purchase or contract
to purchase or grant any option, right or warrant to purchase Common Stock or securities convertible, exercisable or exchangeable into
Common Stock or any other Lock-Up Securities, (4) file or cause to be filed a registration statement, including any amendments, with
respect to the registration of any Lock-Up Securities, (5) establish or increase a put equivalent position or liquidate or decrease a
call equivalent position in Lock-Up Securities or (6) agree to or publicly disclose the intention to do any of the foregoing, in each
case without the prior written consent of the Representative on behalf of the Underwriters; provided, however, that the following shall
not be prohibited by the foregoing: (i) the adoption of an equity incentive plan approved by the Company&rsquo;s independent directors,
and the grant of awards or equity pursuant to any such equity incentive plan or existing plan disclosed in the Registration Statement
to officers, directors, employees or consultants of the Company or any of its subsidiaries, and the filing of a registration statement
on Form S-8 relating thereto; and (ii) the issuance of equity securities in connection with an acquisition or a strategic relationship,
which may include the sale of Lock-Up Securities, and the filing of a registration statement on Form S-4 relating thereto, provided that
any such issuance shall only be to an entity (or to the equity holders of an entity) which is, itself or through its subsidiaries, an
operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company
additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities; provided further that
none of such Lock-Up Securities described in (i) and (ii) above shall be saleable in the public market until the expiration of the Lock-Up
Period, and in no event may any issuance of Lock-Up Securities described in (i) and (ii) above be at a price less than the public offering
price of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
 &nbsp;&nbsp;To cause each officer and director of the Company set forth on&nbsp;<U>Schedule V</U>&nbsp;hereto
to furnish to the Representative, prior to the Delivery Date, a letter or letters, in the form of&nbsp;<U>Exhibit A</U>&nbsp;hereto (the
&ldquo;<B>Lock-Up Agreements</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi) To
apply the net proceeds from the sale of the Securities being sold by the Company as set forth in the Registration Statement, the Pricing
Disclosure Package and the Prospectus under the caption &ldquo;Use of Proceeds&rdquo;;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii) To
not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result
in, stabilization or manipulation of the price of any securities of the Company to facilitate the sale or resale of the Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii) If
at any time following the distribution of any Written Testing-the-Waters Communication there occurred or occurs an event or development
as a result of which such Written Testing-the-Waters Communication included or would include an untrue statement of a material fact or
omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing
at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at
its own expense, such Written Testing-the-Waters Communication to eliminate or correct such untrue statement or omission. The Company
will promptly notify the Representative of (i) any distribution by the Company of Written Testing-the-Waters Communications and (ii)
any request by the Commission for information concerning the Written Testing-the-Waters Communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv) To
do and perform all things required or necessary to be done and performed under this Agreement by it prior to the Delivery Date, and to
satisfy all conditions precedent to the Underwriters&rsquo; obligations hereunder to purchase the Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Each
Underwriter severally agrees that such Underwriter shall not include any &ldquo;issuer information&rdquo; (as defined in Rule 433) in
any &ldquo;free writing prospectus&rdquo; (as defined in Rule 405) used or referred to by such Underwriter without the prior consent
of the Company (any such issuer information with respect to whose use the Company has given its consent, &ldquo;<B>Permitted Issuer Information</B>&rdquo;);&nbsp;<I>provided</I>&nbsp;that
(i) no such consent shall be required with respect to any such issuer information contained in any document filed by the Company with
the Commission prior to the use of such free writing prospectus and (ii) &ldquo;issuer information,&rdquo; as used in this Section 5(b),
shall not be deemed to include information prepared by or on behalf of such Underwriter on the basis of or derived from issuer information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <I>Expenses.</I> (a)
The Company agrees, whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, to
pay all costs, expenses, fees and taxes incident to and in connection with (a) the authorization, issuance, sale and delivery of the
Securities and any stamp duties or other taxes payable in that connection, and the preparation and printing of certificates for the Securities;
(b) the preparation, printing and filing under the Securities Act of the Registration Statement (including any exhibits thereto), any
Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication and any amendment
or supplement thereto; (c) the distribution of the Registration Statement (including any exhibits thereto), any Preliminary Prospectus,
the Prospectus, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication and any amendment or supplement thereto,
all as provided in this Agreement; (d) any required review by FINRA of the terms of sale of the Securities; (e) the listing of the Shares
and the Warrant Shares on The NASDAQ Capital Market or any other exchange; (f) the qualification of the Securities under the securities
laws of the several jurisdictions as provided in Section 5(a)(viii) and the preparation, printing and distribution of a Blue Sky Memorandum
(including related fees and expenses of counsel to the Underwriters); (g) the investor presentations on any &ldquo;road show&rdquo; or
any Written Testing-the-Waters Communication undertaken in connection with the marketing of the Securities, including, without limitation,
expenses associated with any electronic roadshow and the reasonable travel and lodging expenses of the Representative and officers of
the Company; the cost of any aircraft chartered in connection with the road show; (h) all other costs and expenses incident to the performance
of the obligations of the Company under this Agreement, and any transfer taxes payable in connection with its sale of the Securities
to the Underwriters; (i) any disbursements by the Representative relating to background checks of the Company&rsquo;s officers and directors
(not to exceed $5,000 per person); and (h) all other fees and expenses incurred by the Representative in connection with the offering,
including the reasonable fees and expenses of Underwriters&rsquo; counsel,&nbsp;<I>provided</I>&nbsp;that such fees and expenses of Underwriters&rsquo;
counsel shall not exceed $100,000 without the Company&rsquo;s prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &nbsp;&nbsp;On
the Delivery Date, the Company shall pay to the Underwriters, by deduction from the proceeds of the sale of the Securities, an aggregate
management fee equal to one percent (1.0%) of the gross proceeds (based on the public offering price) from the sale of the Securities,
allocated equally between them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. <I>Conditions
of Underwriters&rsquo; Obligations</I>. The respective obligations of the Underwriters hereunder are subject to the accuracy, when made
and on the Delivery Date, of the representations and warranties of the Company contained herein, to the performance by the Company of
its obligations hereunder, and to each of the following additional terms and conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Prospectus shall have been timely filed with the Commission in accordance with Section 5(a)(i); the Company shall have complied with
all filing requirements applicable to any Issuer Free Writing Prospectus used or referred to after the date hereof; the Registration
Statement, including any Rule 462(b) Registration Statement, has become effective and, at the Delivery Date, no stop order suspending
the effectiveness of the Registration Statement or preventing or suspending the use of the Prospectus or any Issuer Free Writing Prospectus
shall have been issued and no proceeding or examination for such purpose shall have been initiated or threatened, or to the knowledge
of the Company or the Representative, contemplated by the Commission; and any request of the Commission for inclusion of additional information
in the Registration Statement or the Prospectus or otherwise shall have been complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
representations and warranties of the Company contained herein shall be true and correct on the date hereof and on and as of the Delivery
Date; and the statements of the Company and its officers made in any certificates delivered pursuant to this Agreement shall be true
and correct on and as of the Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) No
Underwriter shall have discovered and disclosed to the Company on or prior to the Delivery Date that the Registration Statement, the
Prospectus or the Pricing Disclosure Package, or any amendment or supplement thereto, contains an untrue statement of a fact which, in
the reasonable opinion of counsel for the Underwriters, is material or omits to state a fact which, in the reasonable opinion of such
counsel, is material and is required to be stated therein or is necessary to make the statements therein not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) All
corporate proceedings and other legal matters incident to the authorization, form and validity of this Agreement, the Warrants, the Shares,
the Warrant Shares, the Registration Statement, the Prospectus and any Issuer Free Writing Prospectus, and all other legal matters relating
to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all material respects to counsel for the
Underwriters, and the Company shall have furnished to such counsel all documents and information that they may reasonably request to
enable them to pass upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Sheppard,
Mullin, Richter &amp; Hampton LLP shall have furnished to the Representative its written opinion and negative assurance letter, as counsel
to the Company, addressed to the Underwriters and dated the Delivery Date, in form and substance reasonably satisfactory to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Ogawa,
P.C., intellectual property counsel to the Underwriters, shall have furnished to the Representative its written opinion and negative
assurance letter, addressed to the Underwriters and dated the Delivery Date, in form and substance reasonably satisfactory to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) The
Company shall have delivered the Underwriter Warrants to the Representative or as the Representative may otherwise direct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &nbsp;
On the date of this Agreement and on the Delivery Date, Turner, Stone &amp; Company, L.L.P. shall have furnished to the Representative,
at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form and
substance reasonably satisfactory to the Representative, containing statements and information of the type customarily included in accountants&rsquo;
&ldquo;comfort letters&rdquo; to underwriters with respect to the financial statements and certain financial information contained or
incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus;&nbsp;<I>provided</I>&nbsp;that
the letters delivered on the Delivery Date shall use a &ldquo;cut-off&rdquo; date no more than two (2) business days prior to the Delivery
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) On
the date of this Agreement and on the Delivery Date, the Company shall have furnished to the Representative a certificate, dated the
respective dates of delivery thereof and addressed to the Underwriters, of its chief financial officer with respect to certain financial
data contained in the Pricing Disclosure Package and the Prospectus, providing &ldquo;management comfort&rdquo; with respect to such
information, in form and substance reasonably satisfactory to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) The
Company shall have furnished to the Representative a certificate, dated the Delivery Date, of its principal executive officer and its
principal financial officer stating that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) the
representations, warranties and agreements of the Company in Section&nbsp;1 are true and correct on and as of the Delivery Date, and
the Company has complied with all its agreements contained herein and satisfied all the conditions on its part to be performed or satisfied
hereunder at or prior to the Delivery Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) no
stop order suspending the effectiveness of the Registration Statement has been issued; and no proceedings or examination for that purpose
have been instituted or threatened or, to the knowledge of such officers, contemplated;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) subsequent
to the date of the most recent financial statements in the Pricing Disclosure Package, there has been no material adverse change, nor
any development or event involving a prospective material adverse change, in the condition (financial or otherwise), results of operations,
business, properties or prospects of the Company and its subsidiaries taken as a whole except as set forth in the Pricing Disclosure
Package or as described in such certificate; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) they
have carefully examined the Registration Statement, the Prospectus and the Pricing Disclosure Package, and, in their opinion, (A) (1)
the Registration Statement, as of the Effective Date, (2) the Prospectus, as of its date and on the Delivery Date, and (3) the Pricing
Disclosure Package, as of the Applicable Time, did not and do not contain any untrue statement of a material fact and did not and do
not omit to state a material fact required to be stated therein or necessary to make the statements therein (except in the case of the
Registration Statement and the Prospectus, in the light of the circumstances under which they were made) not misleading, and (B) since
the Effective Date, no event has occurred that should have been set forth in a supplement or amendment to the Registration Statement,
the Prospectus or any Issuer Free Writing Prospectus that has not been so set forth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
(i) Neither the Company nor any of its subsidiaries shall have sustained, since the date of the latest audited financial statements included
or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, any loss or interference
with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or
dispute or from any court, regulatory authority or governmental action, order or decree, and (ii) since such date there shall not have
been any change in the capital stock or long-term debt or net current assets of the Company or any of its subsidiaries or any change,
or any development involving a prospective change, in or affecting the condition (financial or otherwise), results of operations, stockholders&rsquo;
equity, properties, management, business or prospects of the Company and its subsidiaries taken as a whole, the effect of which, in any
such case described in clause (i) or (ii), is, in the judgment of the Representative, so material and adverse as to make it impracticable
or inadvisable to proceed with the public offering or the delivery of the Securities being delivered on the Delivery Date on the terms
and in the manner contemplated in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) Subsequent
to the execution and delivery of this Agreement there shall not have occurred any of the following: (i) trading in securities generally
on the New York Stock Exchange, the NYSE Amex or Nasdaq Capital Market, or trading in any securities of the Company on any exchange,
shall have been suspended or materially limited or the settlement of such trading generally shall have been materially disrupted or minimum
prices shall have been established on any such exchange or such market by the Commission, by such exchange or by any other regulatory
body or governmental authority having jurisdiction, (ii) a banking moratorium shall have been declared by federal or state authorities,
(iii) any attack on, or outbreak involving the United States, the United States shall have become engaged in hostilities, there shall
have been an escalation in hostilities involving the United States or there shall have been a declaration of a national emergency or
war by the United States or (iv) there shall have occurred such a material adverse change in general economic, political or financial
conditions, including, without limitation, as a result of terrorist activities after the date hereof (or the effect of international
conditions on the financial markets in the United States shall be such), as to make it, in the judgment of the Representative, impracticable
or inadvisable to proceed with the public offering or delivery of the Securities being delivered on the Delivery Date on the terms and
in the manner contemplated in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) The
Company shall have submitted a listing of additional shares notification form to NASDAQ with respect to the Shares and the Warrant Shares
and shall have received no objection thereto from NASDAQ.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) The
Representative shall have received on and as of the Delivery Date satisfactory evidence of the good standing of the Company and its subsidiaries
in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Representative may reasonably
request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) The
Lock-Up Agreements between the Representative and each officer and director of the Company set forth on&nbsp;<U>Schedule V</U>&nbsp;hereto
shall have been delivered to the Representative on or before the date of this Agreement and shall be in full force and effect on the
Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) The
Company shall have furnished such other opinions, certificates, letters and documents as the Representative reasonably requests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
opinions, letters, evidence and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with
the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <I>Indemnification
and Contribution.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Company shall indemnify and hold harmless each Underwriter, its directors, officers, employees, partners, agents, affiliates and each
person, if any, who controls any Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act
(each an &ldquo;<B>Indemnified Party</B>&rdquo;), from and against any and all loss, claim, damage or liability, joint or several, or
any action in respect thereof (including, but not limited to, any loss, claim, damage, liability or action relating to purchases and
sales of Shares), to which such Indemnified Party may become subject, under the Securities Act, the Exchange Act, other federal or state
statutory law or otherwise, insofar as such loss, claim, damage or liability (or action in respect thereof) arises out of, or is based
upon, (i) any untrue statement or alleged untrue statement of a material fact contained in (A) any Preliminary Prospectus as of any time,
any part of any Registration Statement at any time, the Pricing Disclosure Package, the Prospectus or in any amendment or supplement
thereto, (B) any Issuer Free Writing Prospectus or in any amendment or supplement thereto or (C) any Permitted Issuer Information used
or referred to in any &ldquo;free writing prospectus&rdquo; (as defined in Rule 405) used or referred to by any Underwriter or (D) any
&ldquo;road show&rdquo; (as defined in Rule 433) or investor presentation not constituting an Issuer Free Writing Prospectus and any
Written Testing-the-Waters Communication (&ldquo;<B>Marketing Materials</B>&rdquo;) or (ii) the omission or alleged omission to state
in any Preliminary Prospectus, any part of any Registration Statement, the Pricing Disclosure Package, the Prospectus, any Issuer Free
Writing Prospectus or in any amendment or supplement thereto or in any Permitted Issuer Information or any Marketing Materials, any material
fact required to be stated therein or necessary to make the statements therein not misleading, and shall reimburse each Indemnified Party
promptly upon demand for any legal or other expenses reasonably incurred by such Indemnified Party in connection with investigating or
defending or preparing to defend against any such loss, claim, damage, liability, action, litigation, investigation or proceeding whatsoever
(whether or not such Indemnified Party is a party thereto), whether threatened or commenced, as such expenses are incurred;&nbsp;<I>provided</I>,&nbsp;<I>however</I>,
that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out
of, or is based upon, an untrue statement or alleged untrue statement or omission or alleged omission made in any of such documents,
in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by the Representative
on behalf of any Underwriter specifically for inclusion therein, which information consists solely of the information specified in Section
8(e). The foregoing indemnity agreement is in addition to any liability which the Company may otherwise have to any Indemnified Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Each
Underwriter, severally and not jointly, shall indemnify and hold harmless the Company, its directors, officers who sign a Registration
Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act (each an &ldquo;<B>Underwriter Indemnified Party</B>&rdquo;), from and against any loss, claim, damage or liability, joint
or several, or any action in respect thereof, to which such Underwriter Indemnified Party may become subject, under the Securities Act,
the Exchange Act, other federal or state statutory law or regulation or otherwise, insofar as such loss, claim, damage, liability or
action arises out of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in any Preliminary
Prospectus, any Registration Statement, the Pricing Disclosure Package, the Prospectus, any Issuer Free Writing Prospectus or in any
amendment or supplement thereto or in any Marketing Materials, or (ii) the omission or alleged omission to state in any Preliminary Prospectus,
any Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Marketing
Materials, any material fact required to be stated therein or necessary to make the statements therein not misleading, but in each case
only to the extent that the untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and
in conformity with information relating to any Underwriter furnished to the Company in writing by the Representative on behalf of any
Underwriter specifically for inclusion therein, which information is limited to the information set forth in Section 8(e). The foregoing
indemnity agreement is in addition to any liability that any Underwriter may otherwise have to an Underwriter Indemnified Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Promptly
after receipt by an indemnified party under this Section 8 of notice of any claim or the commencement of any action, the indemnified
party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section 8, notify the indemnifying
party in writing of the claim or the commencement of that action;&nbsp;<I>provided</I>,<I>&nbsp;however</I>, that the failure to notify
the indemnifying party shall not relieve it from any liability that it may have under this Section 8 except to the extent it has been
materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure and,&nbsp;<I>provided</I>,&nbsp;<I>further</I>,
that the failure to notify the indemnifying party shall not relieve it from any liability which it may have to an indemnified party otherwise
than under this Section 8. If any such claim or action is brought against an indemnified party, and it notifies the indemnifying party
thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly
notified indemnifying party, to assume the defense thereof with counsel reasonably satisfactory to the indemnified party (who shall not,
except with the consent of the indemnified party, be counsel to the indemnifying party). After notice from the indemnifying party to
the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall not be liable to the
indemnified party under this Section 8 for any legal or other expenses subsequently incurred by the indemnified party in connection with
the defense thereof other than reasonable costs of investigation;&nbsp;<I>provided, however</I>, that the indemnified party shall have
the right to employ counsel to represent jointly the indemnified party and those other indemnified parties who may be subject to liability
arising out of any claim in respect of which indemnity may be sought under this Section 8 if (i) the indemnified party and the indemnifying
party shall have so mutually agreed; (ii) the indemnifying party has failed within a reasonable time to retain counsel reasonably satisfactory
to the indemnified party; (iii) the indemnified party shall have reasonably concluded that there may be legal defenses available to them
that are different from or in addition to those available to the indemnifying party; or (iv) the named parties in any such proceeding
(including any impleaded parties) include both the indemnified parties or their respective directors, officers, employees, partners,
agents, affiliates or controlling persons, on the one hand, and the indemnifying party, on the other hand, and representation of both
sets of parties by the same counsel would be inappropriate due to actual or potential differing interests between them, and in any such
event the reasonable fees and expenses of such separate counsel shall be paid by the indemnifying party (but the indemnifying party shall
not be liable for the fees and expenses of more than one law firm (in addition to any local counsel) for the indemnified party). No indemnifying
party shall (i)&nbsp;without the prior written consent of the indemnified party (which consent shall not be unreasonably withheld), settle
or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in
respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential
parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of such indemnified
party from all liability arising out of such claim, action, suit or proceeding and does not include any findings of fact or admissions
of fault or culpability as to the indemnified party, or (ii) be liable for any settlement of any such action effected without its written
consent (which consent shall not be unreasonably withheld), but if settled with the consent of the indemnifying party or if there be
a final judgment for the plaintiff in any such action, the indemnifying party agrees to indemnify and hold harmless any indemnified party
from and against any loss or liability by reason of such settlement or judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) If
the indemnification provided for in this Section 8 shall for any reason be unavailable to or insufficient to hold harmless an indemnified
party under Section 8(a) or 8(b) in respect of any loss, claim, damage or liability, or any action in respect thereof, referred to therein,
then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount paid or payable by such
indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, (i) in such proportion as shall
be appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters, on the other, from the
offering of the Securities or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion
as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company,
on the one hand, and the Underwriters, on the other, with respect to the statements or omissions that resulted in such loss, claim, damage
or liability, or action in respect thereof, as well as any other relevant equitable considerations. The relative benefits received by
the Company, on the one hand, and the Underwriters, on the other, with respect to such offering shall be deemed to be in the same proportion
as the total net proceeds from the offering of the Securities purchased under this Agreement (before deducting expenses) received by
the Company, as set forth in the table on the cover page of the Prospectus, on the one hand, and the total underwriting discounts and
commissions received by the Underwriters with respect to the Securities purchased under this Agreement, as set forth in the table on
the cover page of the Prospectus, on the other hand. The relative fault shall be determined by reference to whether the untrue or alleged
untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company
or the Underwriters, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent
such statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant
to this Section 8(d) were to be determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose)
or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid
or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above
in this Section 8(d) shall be deemed to include, for purposes of this Section 8(d), any legal or other expenses reasonably incurred by
such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this
Section 8(d), no Underwriter shall be required to contribute any amount in excess of the underwriting discounts and commissions received
by it. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&rsquo; obligations to contribute
as provided in this Section 8(d) are several in proportion to their respective underwriting obligations and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) The
Underwriters severally confirm and the Company acknowledges and agrees that the concession and reallowance figures and the paragraph
relating to stabilization by the Underwriters appearing under the caption &ldquo;Underwriting&rdquo; in, the most recent Preliminary
Prospectus and the Prospectus constitute the only information concerning such Underwriters furnished in writing to the Company by or
on behalf of the Underwriters specifically for inclusion in any Preliminary Prospectus, any Registration Statement, the Pricing Disclosure
Package, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Marketing Materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <I>Defaulting
Underwriters</I>. If, on the Delivery Date, any Underwriter defaults in the performance of its obligations to purchase Shares under this
Agreement, the remaining non-defaulting Underwriters shall be obligated to purchase or make arrangements reasonably satisfactory to the
Company for other persons to purchase the Securities that the defaulting Underwriter agreed but failed to purchase on the Delivery Date
in the respective proportions which the number of Securities set forth opposite the name of each remaining non-defaulting Underwriter
in&nbsp;<U>Schedule I</U>&nbsp;hereto bears to the total number of Securities set forth opposite the names of all the remaining non-defaulting
Underwriters in&nbsp;<U>Schedule I</U>&nbsp;hereto;&nbsp;<I>provided, however</I>, that the remaining non-defaulting Underwriters shall
not be obligated to purchase any of the Securities on the Delivery Date if the total number of Securities that the defaulting Underwriter
or Underwriters agreed but failed to purchase on such date exceeds 9.99% of the total number of Securities to be purchased on the Delivery
Date, and any remaining non-defaulting Underwriter shall not be obligated to purchase more than 110% of the number of Shares that it
agreed to purchase on the Delivery Date pursuant to the terms of Section 2. If the foregoing maximums are exceeded, the remaining non-defaulting
Underwriters, or those other underwriters satisfactory to the Representative who so agree, shall have the right, but shall not be obligated,
to purchase, in such proportion as may be agreed upon among them, all the Securities to be purchased on the Delivery Date. If the remaining
Underwriters or other underwriters satisfactory to the Representative do not elect within 36 hours of the default to purchase the Securities
that the defaulting Underwriter or Underwriters agreed but failed to purchase on the Delivery Date, this Agreement shall terminate without
liability on the part of any non-defaulting Underwriter or the Company, except as provided in Section 16 and except that the Company
will continue to be liable for the payment of expenses to the extent set forth in Sections 6 and 11. As used in this Agreement, the term
&ldquo;Underwriter&rdquo; includes, for all purposes of this Agreement unless the context requires otherwise, any party not listed in&nbsp;<U>Schedule
I</U>&nbsp;hereto that, pursuant to this Section 9, purchases Shares that a defaulting Underwriter agreed but failed to purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company for damages caused by its default.
If other Underwriters are obligated or agree to purchase the Securities of a defaulting or withdrawing Underwriter, either the Representative
or the Company may postpone the Delivery Date for up to seven (7) full business days in order to effect any changes that in the opinion
of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement, the Prospectus or in any other
document or arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <I>Termination.</I> The
obligations of the Underwriters hereunder may be terminated by the Representative by notice given to and received by the Company prior
to delivery of and payment for the Securities if, prior to that time, any of the events described in Sections 7(l) and 7(m) shall have
occurred or if the Underwriters shall decline to purchase the Shares for any reason permitted under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <I>Reimbursement
of Underwriters&rsquo; Expenses.</I> If the Company shall fail to tender the Securities for delivery to the Underwriters
for any reason or (b) the Underwriters shall decline to purchase the Securities for any reason permitted under this Agreement (other
than as a result of any of the events set forth in Section 7(m)), the Company will reimburse the Underwriters for all reasonable out-of-pocket
expenses (including reasonable fees and disbursements of counsel) incurred by the Underwriters in connection with this Agreement and
the proposed purchase of the Securities, and upon demand the Company shall pay the full amount thereof to the Representative (subject
to the limitations set forth in Section 6 hereof). If this Agreement is terminated pursuant to Section 9 by reason of the default of
one or more Underwriters, the Company shall not be obligated to reimburse any defaulting Underwriter on account of those expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12. <I>Research
Analyst Independence.&nbsp;</I>The Company acknowledges that the Underwriters&rsquo; research analysts and research departments are required
to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and
that such Underwriters&rsquo; research analysts may hold views and make statements or investment recommendations and/or publish research
reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions.
The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters
with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts
and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters&rsquo;
investment banking divisions. The Company acknowledges that each of the Underwriters is a full-service securities firm and as such from
time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and
hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <I>No
Fiduciary Duty</I>. The Company acknowledges and agrees that in connection with this offering, sale of the Securities or any other services
the Underwriters may be deemed to be providing hereunder, notwithstanding any preexisting relationship, advisory or otherwise, between
the parties or any oral representations or assurances previously or subsequently made by the Underwriters: (i) no fiduciary or agency
relationship between the Company and any other person, on the one hand, and the Underwriters, on the other, exists; (ii) the Underwriters
are not acting as advisors, expert or otherwise, to the Company, including, without limitation, with respect to the determination of
the public offering price of the Securities, and such relationship between the Company, on the one hand, and the Underwriters, on the
other, is entirely and solely commercial, based on arms-length negotiations; (iii) any duties and obligations that the Underwriters may
have to the Company shall be limited to those duties and obligations specifically stated herein; and (iv) the Underwriters and their
respective affiliates may have interests that differ from those of the Company. The Company hereby waives any claims that the Company
may have against the Underwriters with respect to any breach of fiduciary duty in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14. <I>Notices,
Etc.</I> All statements, requests, notices and agreements hereunder shall be in writing, and:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) if
to the Underwriters, shall be delivered or sent by mail or facsimile transmission to Laidlaw &amp; Company (UK) Ltd., 521 Fifth Avenue,
12th Floor, New York, NY 10175, Attention: Francis Ryan Smith, Vice President, Email: fsmith@laidlawltd.com, with a copy (which shall
not constitute notice) to Sichenzia Ross Ference LLP, 1185 Avenue of the Americas, 31<SUP>st</SUP> Floor, New York, NY 10036, Attention:
Michael Ference, Esq., mference@srfc.law; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) if
to the Company, shall be delivered or sent by mail or facsimile transmission to Amesite Inc., 607 Shelby St. Ste. 700, PMB 214, Detroit,
MI 48266, Attention: Chief Executive Officer, Email: ams@amesite.io, with a copy (which shall not constitute notice) to Sheppard, Mullin,
Richter &amp; Hampton LLP, 30 Rockefeller Plaza, 38<SUP>th</SUP> Floor, New York, New York 10112, Attention: Richard A. Friedman, Email:
rafriedman@sheppardmullin.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such statements, requests, notices or agreements shall take effect at the time of receipt thereof. The Company shall be entitled to act
and rely upon any request, consent, notice or agreement given or made on behalf of the Underwriters by Laidlaw &amp; Company (UK) Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15. <I>Persons
Entitled to Benefit of Agreement</I>. This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Company
and their respective successors. This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except
that (A) the representations, warranties, indemnities and agreements of the Company contained in this Agreement shall also be deemed
to be for the benefit of the directors, officers and employees of the Underwriters and each person or persons, if any, who control any
Underwriter within the meaning of Section&nbsp;15 of the Securities Act and (B) the indemnity agreement of the Underwriters contained
in Section&nbsp;8(b) of this Agreement shall be deemed to be for the benefit of the directors of the Company, the officers of the Company
who have signed the Registration Statement and any person controlling the Company within the meaning of Section&nbsp;15 of the Securities
Act. Nothing in this Agreement is intended or shall be construed to give any person, other than the persons referred to in this Section
15, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16. <I>Survival.</I> The
respective indemnities, representations, warranties and agreements of the Company and the Underwriters contained in this Agreement or
made by or on behalf of them, respectively, pursuant to this Agreement, shall survive the delivery of and payment for the Securities
and shall remain in full force and effect, regardless of any investigation made by or on behalf of any of them or any person controlling
any of them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17. <I>Definition
of the Terms &ldquo;Business Day&rdquo; and &ldquo;Subsidiary&rdquo;</I>. For purposes of this Agreement, (a) &ldquo;<B>business day</B>&rdquo;
means each Monday, Tuesday, Wednesday, Thursday or Friday that is not a day on which banking institutions in New York are generally authorized
or obligated by law or executive order to close and (b) &ldquo;<B>subsidiary</B>&rdquo; has the meaning set forth in Rule&nbsp;405.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18. <I>Governing
Law</I>.&nbsp;<B>This Agreement shall be governed by and construed in accordance with the laws of the State of New York.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19. <I>Counterparts.</I> This
Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts shall
each be deemed to be an original but all such counterparts shall together constitute one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20. <I>Amendments
or Waivers</I>. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall
in any event be effective unless the same shall be in writing and signed by the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21. <I>Headings.</I> The
headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation
of, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth the agreement between the Company and the Underwriters, please indicate your acceptance in the space
provided for that purpose below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly
    yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMESITE INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ann Marie
    Sastry</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ann Marie Sastry</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
&amp; Company (UK) Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
itself and as Representative<BR>
of the several Underwriters named<BR>
in&nbsp;<U>Schedule I</U>&nbsp;hereto</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Luke Kottke</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authorized Representative</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
I</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Underwriters</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Number of Shares</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Number of Pre-Funded Warrants</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Laidlaw &amp; Company (UK) Ltd.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">857,502</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Craft Capital Management LLC</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">344,165</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">  &nbsp;&nbsp;0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,201,667</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
II</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ORALLY
CONVEYED PRICING INFORMATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Shares to be Issued: 1,201,667</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Pre-Funded Warrants to be Issued: 0</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Share: $3.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Pre-Funded Warrant: $2.999</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
price per share of Pre-Funded Warrants: $0.0001</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
III</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PERMITTED
WRITTEN TESTING-THE-WATERS COMMUNICATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[None.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
IV</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY
INVESTORSS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ann
Marie Sastry, Ph.D - $1,000,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gilbert
S. Omenn, M.D., Ph.D. - $10,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
V</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOCK-UP
SIGNATORIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Directors
and Officers</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ann
Marie Sastry, Ph.D</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sarah
Berman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Barbie
Brewer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.
Michael Losh&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gilbert
S. Omenn, M.D., Ph.D.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">George
Parmer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF LOCK-UP LETTER AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amesite
Inc.<BR>
Lock-Up Letter Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
[*], 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
&amp; Company (UK) Ltd.,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
representative of the several Underwriters</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c/o
Laidlaw &amp; Company (UK) Ltd.<BR>
521 Fifth Avenue, 5<SUP>th</SUP> Floor<BR>
New York, New York 10175</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Proposed
Public Offering by Amesite Inc.</U></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, a securityholder of Amesite Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), understands that Laidlaw &amp;
Company (UK) Ltd. (the &ldquo;<B>Representative</B>&rdquo;), proposes to enter into an Underwriting Agreement (the &ldquo;<B>Underwriting
Agreement</B>&rdquo;) with the Company providing for the public offering (the &ldquo;<B>Public Offering</B>&rdquo;) of shares of the
Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;) and pre-funded warrants to purchase
Common Stock. In recognition of the benefit that such an offering will confer upon the undersigned as a securityholder of the Company,
and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned (or any
affiliate of the undersigned or any person in privity with the undersigned or any affiliate of the undersigned) agrees with the Representative
that, during a period commencing on the date hereof and ending on the thirtieth (30<SUP>th</SUP>) day after the Delivery Date (as defined
in the Underwriting Agreement) (the &ldquo;<B>Lock-Up Period</B>&rdquo;), the undersigned will not, without the prior written consent
of the Representative, directly or indirectly, (i)&nbsp;offer, pledge, sell or contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant for the sale of, or otherwise dispose of or transfer any
Common Stock or any securities convertible into or exchangeable or exercisable for Common Stock, whether now owned or hereafter acquired
by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition, or file, make any demand
with respect to, cause to be filed, or exercise any right with respect to any registration statement under the Securities Act of 1933,
as amended (the &ldquo;<B>Securities Act</B>&rdquo;), with respect to any of the foregoing (collectively, the &ldquo;<B>Lock-Up Securities</B>&rdquo;),
(ii)&nbsp;enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly,
the economic consequence of ownership of Lock-Up Securities, whether any such swap or transaction is to be settled by delivery of Common
Stock or other securities, in cash or otherwise or (iii) engage in any short selling of the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, and subject to the conditions below, the undersigned may transfer the Lock-Up Securities without the prior written consent
of the Representative, provided that (1)&nbsp;the Representative receives a signed lock-up agreement for the balance of the lockup period
from each donee, trustee, distributee, or transferee, as the case may be, (2)&nbsp;any such transfer shall not involve a disposition
for value, (3)&nbsp;such transfers are not required to be reported with the Securities and Exchange Commission in accordance with the
Securities Exchange Act of 1934, as amended the (&ldquo;<B>Exchange Act</B>&rdquo;) under Section 16 or otherwise, and (4)&nbsp;neither
the undersigned nor any donee, trustee, distributee or transferee, as the case may be, otherwise voluntarily effects any public filing
or report or other public notice regarding such transfers:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
as a <I>bona fide</I> gift or gifts; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
to any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned (for purposes of this lock-up
agreement, &ldquo;immediate family&rdquo; shall mean any relationship by blood, marriage or adoption, not more remote than first cousin);
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
as a distribution to limited partners or stockholders of the undersigned; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
to any investment fund or other entity controlled or managed by the undersigned; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
transfers by will, other testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of
the immediate family of the undersigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, this letter agreement shall not restrict the delivery of Common Stock to the undersigned upon vesting and settlement of restricted
share units or exercise of options outstanding on the date hereof in accordance with their terms; provided, for the avoidance of doubt,
that this letter agreement shall restrict the Common Stock delivered upon any such vesting, settlement or exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the undersigned may sell shares of Common Stock purchased by the undersigned on the open market following the Offering if and only if
(i)&nbsp;such sales are not required to be reported in any public report or filing with the Securities Exchange Commission in accordance
with the Exchange Act under Section 16 or otherwise and (ii)&nbsp;neither the undersigned nor any purchaser of the Common Stock otherwise
voluntarily effects any public filing or report or other public notice regarding such sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything in the first paragraph hereof, if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
during the last seventeen (17) days of the Lock-Up Period, the Company issues an earnings release or material news or a material event
relating to the Company occurs; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
prior to the expiration of the Lock-Up Period, the Company announces that it will release earnings results or becomes aware that material
news or a material event will occur during the sixteen- (16-) day period beginning on the last day of the Lock-Up Period,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Representative may extend, by written notice to the Company, the restrictions imposed by this lock-up agreement until the expiration
of the eighteen- (18-) day period beginning on the issuance of the earnings release or the occurrence of the material news or material
event, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby acknowledges and agrees that written notice of any extension of the Lock-Up Period pursuant to the previous paragraph
will be delivered by the Representative to the Company (in accordance with the notice section of the Underwriting Agreement) and that
any such notice properly delivered will be deemed to have been given to, and received by, the undersigned. The undersigned further agrees
that, prior to engaging in any transaction or taking any other action that is subject to the terms of this lock-up agreement during the
period from the date of this lock-up agreement to and including the 34th day following the expiration of the initial Lock-Up Period,
it will give notice thereof to the Company and will not consummate such transaction or take any such action unless it has received written
confirmation from the Company that the Lock-Up Period (as may have been extended pursuant to the previous paragraph) has expired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
furtherance of the foregoing, the undersigned also agrees and consents to the entry of stop transfer instructions with the Company&rsquo;s
transfer agent and registrar against the transfer of the Lock-Up Securities except in compliance with the foregoing restrictions and
the Company and its transfer agent are hereby authorized to decline to make any transfer of Lock-Up Securities if such transfer would
constitute a violation or breach of this agreement. In addition, the undersigned further agrees that (i)&nbsp;it will not, during the
Lock-Up Period, make any demand or request for or exercise any right with respect to the registration under the Securities Act of any
Lock-Up Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
letter agreement shall automatically terminate if (i)&nbsp;the Company notifies the Representative in writing that it does not intend
to proceed with the Public Offering, (ii) if the Underwriting Agreement is not executed prior to [*], 2025, or (iii) if the Underwriting
Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery
of the Common Stock to be sold thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
agreement shall be governed by and construed in accordance with the laws of the State of New York.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-4</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ea022707301ex4-1_amesite.htm
<DESCRIPTION>FORM OF UNDERWRITERS WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH
SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Underwriter&rsquo;s Warrant</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2pt">.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.2pt">VOID AFTER 5:00 P.M., EASTERN
TIME, <B>JANUARY <FONT STYLE="text-transform: uppercase">7, 2030.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the Purchase of [*] Shares of Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AMESITE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">1. &nbsp;<U>Purchase
Warrant</U>. THIS CERTIFIES THAT, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, <B>[*]
</B>(together with any permitted assign hereunder, the &ldquo;<B>Holder</B>&rdquo;), as registered owner of this Purchase Warrant, is
entitled, at any time or from time to time from <B>JANUARY [*], 2025</B> (the &ldquo;<B>Commencement Date</B>&rdquo;), and at or before
5:00 p.m., Eastern time, <B>JANUARY 7, 2030</B> (the &ldquo;<B>Expiration Date</B>&rdquo;), but not thereafter, to subscribe for, purchase
and receive, in whole or in part, up to <B>[*] ([*]) shares</B> (the &ldquo;<B>Shares</B>&rdquo;) of common stock, par value $0.0001 per
share (the &ldquo;<B>Common Stock</B>&rdquo;), of <B>AMESITE INC.</B>, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), subject
to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized or required
by law or executive order to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in
accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would
terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $3.75 per Share; <U>provided</U>, <U>however</U>, that
upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise
price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. This Purchase Warrant
is being issued in connection with a public offering of shares of Common Stock pursuant to the Company&rsquo;s registration statement
on Form S-3 (File No.: 333-282999) (the &ldquo;<B>Offering</B>&rdquo;). The term &ldquo;<B>Exercise Price</B>&rdquo; shall mean the initial
exercise price or the adjusted exercise price, depending on the context.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">2. &nbsp;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;<U>Exercise
Form</U>. In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and completed and delivered
to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Shares being purchased payable in cash by
wire transfer of immediately available funds to an account designated by the Company or by certified check or official bank check. If
the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date, this Purchase
Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;<U>Cashless
Exercise</U>. If at any time after the Commencement Date there is no effective registration statement registering, or no current prospectus
available for, the resale of the Shares by the Holder, in lieu of exercising this Purchase Warrant by payment of cash or check payable
to the order of the Company pursuant to Section 2.1 above, Holder may elect to receive the number of Shares equal to the value of this
Purchase Warrant (or the portion thereof being exercised), by surrender of this Purchase Warrant to the Company, together with the exercise
form attached hereto, in which event the Company will issue to Holder Shares in accordance with the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
  <TR>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD>
    <TD COLSPAN="2" ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><U>Y(A-B)</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">A</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Where,</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">X</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">The number of Shares to be issued to Holder;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Y</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">The number of Shares for which the Purchase Warrant is being exercised;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">A</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">The fair market value of one Share; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">B</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">The Exercise Price.</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 79%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Section
2.2, the fair market value of a Share is defined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if the Common Stock is traded
on a securities exchange, the value shall be deemed to be the closing price on such exchange on the trading day prior to the exercise
form being submitted in connection with the exercise of the Purchase Warrant;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if the Common Stock is actively
traded on an over-the-counter market, the value shall be deemed to be the closing bid on the trading day prior to the exercise form being
submitted in connection with the exercise of the Purchase Warrant; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">if there is no active public market
in the United States, the value shall be the fair market value thereof, as determined in good faith by the Company&rsquo;s Board of Directors.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. &nbsp;<U>Transfer</U>.
Transfers of this Purchase Warrant or any of the Shares to others may be made subject to compliance with or exemptions from applicable
securities laws In order to make any assignment of this Purchase Warrant, the Holder must deliver to the Company the assignment form attached
hereto duly executed and completed, together with the Purchase Warrant and payment of all transfer taxes, if any, payable in connection
therewith. The Company shall within five (5) Business Days transfer this Purchase Warrant on the books of the Company and shall execute
and deliver a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to
purchase the aggregate number of Shares purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.
Notwithstanding the foregoing, this Purchase Warrant or portion hereof, if properly assigned in accordance herewith, may be exercised
by the assignee for the purchase of Shares without having received a new Purchase Warrant or Purchase Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Neither
</FONT>this Purchase Warrant nor any of the Shares <FONT STYLE="background-color: white">shall be transferred unless and until: (a) the
Company has received the opinion of counsel for the Holder that the securities may be transferred pursuant to an exemption from registration
under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;) and applicable state securities laws, the availability
of which is established to the reasonable satisfaction of the Company (the Company hereby agreeing that the opinion of </FONT>Sichenzia
Ross Ference Carmel <FONT STYLE="background-color: white">LLP shall be deemed satisfactory evidence of the availability of an exemption),
or (b) a registration statement or a post-effective amendment to a registration statement relating to the offer and sale of such securities
has been filed by the Company and declared effective by the Commission and compliance with applicable state securities law has been established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">4. &nbsp;<U>Registration
Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">4.1&nbsp;[RESERVED<U>]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">4.2&nbsp;<U>&ldquo;Piggy-Back&rdquo;
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.1&nbsp;<U>Grant
of Right</U>. Unless a registration statement covering the exercise of this Purchase Warrant and the sale of the Shares by the Holder
is in effect and available, the Holder shall have the right, for a period of no more than seven (7) years after the commencement of sales
of the Offering, to include all or any portion of the Shares underlying the Purchase Warrants (collectively, the &ldquo;<B>Registrable
Securities</B>&rdquo;) as part of any other registration of securities filed by the Company (other than in connection with a transaction
contemplated by Rule 145(a) promulgated under the Securities Act, or pursuant to Form S-8 or any equivalent form); <U>provided</U>, <U>however</U>,
that if, solely in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s)
thereof shall, in its reasonable discretion, impose a limitation on the number of shares of Common Stock which may be included in the
registration statement because, in such underwriter(s)&rsquo; judgment, marketing or other factors dictate such limitation is necessary
to facilitate public distribution, then the Company shall be obligated to include in such registration statement only such limited portion
of the Registrable Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit.
Any exclusion of Registrable Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion
to the number of Registrable Securities sought to be included by such Holders; <U>provided</U>, <U>however</U>, that the Company shall
not exclude any Registrable Securities unless the Company has first excluded all outstanding securities, the holders of which are not
entitled to inclusion of such securities in such registration statement or are not entitled to pro rata inclusion with the Registrable
Securities. Notwithstanding the foregoing, the Company shall not be required to register any Registrable Securities pursuant to this Section
that are subject of a then effective registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2.2&nbsp;<U>Terms</U>.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 4.2.1 hereof, but
the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent
them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish
the then Holders of outstanding Registrable Securities with not less than fifteen (15) days written notice prior to the proposed date
of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration statement filed
by the Company until such time as all of the Registrable Securities have been sold by the Holder. The holders of the Registrable Securities
shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written notice within five (5) days of the receipt of
the Company&rsquo;s notice of its intention to file a registration statement. Except as otherwise provided in this Purchase Warrant, there
shall be no limit on the number of times the Holder may request registration under this Section 4.2.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&nbsp;<U>General
Terms</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3.1&nbsp;<U>Indemnification</U>.
The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder and
each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20(a) of the Securities
Exchange Act of 1934, as amended (&ldquo;<B>Exchange Act</B>&rdquo;), against all loss, claim, damage, expense or liability (including
all reasonable attorneys&rsquo; fees and other expenses reasonably incurred in investigating, preparing or defending against any claim
whatsoever) to which any of them may become subject under the Securities Act, the Exchange Act or otherwise, arising from such registration
statement but only to the same extent and with the same effect as the provisions pursuant to which the Company has agreed to indemnify
the Underwriters (as defined in the Underwriting Agreement) contained in Section 8(a) of the Underwriting Agreement between Laidlaw &amp;
Company (UK) Ltd. (&ldquo;<B>Laidlaw</B>&rdquo;), as the representative of the several Underwriters named on Schedule I thereto, and the
Company, dated as of January 7, 2025 (the &ldquo;<B>Underwriting Agreement</B>&rdquo;). The Holder(s) of the Registrable Securities to
be sold pursuant to such registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company,
against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other expenses reasonably incurred
in investigating, preparing or defending against any claim whatsoever) to which they may become subject under the Securities Act, the
Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their successors or assigns, in writing,
for specific inclusion in such registration statement to the same extent and with the same effect as the provisions contained in Section
8(b) of the Underwriting Agreement pursuant to which the Underwriters have agreed to indemnify the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3.2&nbsp;<U>Exercise
of Purchase Warrants</U>. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise their Purchase
Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3.3&nbsp;<U>Documents
Delivered to Holders</U>. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each underwriter
of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) if such registration includes an
underwritten public offering, an opinion of counsel to the Company, dated the date of the closing under any underwriting agreement related
thereto, and (ii) if such registration includes an underwritten public offering, a &ldquo;cold comfort&rdquo; letter dated the effective
date of such registration statement and a letter dated the date of the closing under the underwriting agreement, signed by the independent
registered public accounting firm which has issued a report on the Company&rsquo;s financial statements included in such registration
statement, in each case covering substantially the same matters with respect to such registration statement (and the prospectus included
therein) and, in the case of such accountants&rsquo; letter, with respect to events subsequent to the date of such financial statements,
as are customarily covered in opinions of issuer&rsquo;s counsel and in accountants&rsquo; letters delivered to underwriters in underwritten
public offerings of securities. The Company shall also deliver promptly to each Holder participating in the offering requesting the correspondence
and memoranda described below and to the managing underwriter, if any, copies of all correspondence between the Commission and the Company,
its counsel or auditors and all memoranda relating to discussions with the Commission or its staff with respect to the registration statement
and permit each Holder and underwriter to do such investigation, upon reasonable advance notice, with respect to information contained
in or omitted from the registration statement as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA.
Such investigation shall include access to books, records and properties and opportunities to discuss the business of the Company with
its officers and independent auditors, all to such reasonable extent and at such reasonable times as any such Holder shall reasonably
request in connection with the underwritten offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3.4&nbsp;<U>Underwriting
Agreement</U>. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by any Holders
whose Registrable Securities are being registered pursuant to this Section 4, which managing underwriter shall be reasonably satisfactory
to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and such managing underwriters,
and shall contain such representations, warranties and covenants by the Company and such other terms as are customarily contained in agreements
of that type used by the managing underwriter. The Holders shall be parties to any underwriting agreement relating to an underwritten
sale of their Registrable Securities and may, at their option, require that any or all the representations, warranties and covenants of
the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such Holders. Such Holders shall not
be required to make any representations or warranties to or agreements with the Company or the underwriters except as they may relate
to such Holders, their Shares and their intended methods of distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3.5&nbsp;<U>Documents
to be Delivered by Holder(s)</U>. Each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company a
completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders. <FONT STYLE="background-color: white">The
Holder further agrees that it shall not be entitled to be named in a registration statement filed under this Section 4 or use the related
prospectus for offers and resales of Registrable Securities at any time, unless such Holder has returned to the Company a response to
any requests for information as described in the previous sentence. If the Holder returns a request for information after its deadline,
the Company shall use its commercially reasonable efforts to take such actions as are required to name such Holder as a selling security
holder in the registration statement or any pre-effective or post-effective amendment thereto and to include (to the extent not theretofore
included) in the registration statement the Registrable Securities identified in such late request for information. The Holder acknowledges
and agrees that the information in any request for information as described in this Section will be used by the Company in the preparation
of the registration statement registering for resale the Registrable Securities and hereby consents to the inclusion of such information
in such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3.6&nbsp;<U>Damages</U>.
Should the registration or the effectiveness thereof required by Section 4.2 hereof be delayed by the Company or the Company otherwise
fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available to the Holder(s),
be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened breach of such provisions
or the continuation of any such breach, without the necessity of proving actual damages and without the necessity of posting bond or other
security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">5. &nbsp;<U>New
Purchase Warrants to be Issued</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&nbsp;<U>Partial
Exercise</U>. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised in whole or in part. In the event
of the exercise hereof in part only, upon surrender of this Purchase Warrant for cancellation, the Company shall cause to be delivered
to the Holder without charge a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right
of the Holder to purchase the number of Shares purchasable hereunder as to which this Purchase Warrant has not been exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;<U>Lost
Certificate</U>. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase
Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase
Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation or destruction
shall constitute a substitute contractual obligation on the part of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">6.&nbsp;<U>Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.1&nbsp;<U>Adjustments
to Exercise Price and Number of Securities</U>. The Exercise Price and the number of Shares underlying the Purchase Warrant shall be subject
to adjustment from time to time as hereinafter set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.1&nbsp;<U>Share
Dividends; Split Ups</U>. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Shares
is increased by a stock dividend payable in Shares or by a split up of Shares or other similar event, then, on the effective day thereof,
the number of Shares purchasable hereunder shall be increased in proportion to such increase in outstanding Shares, and the Exercise Price
shall be proportionately decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.2 &nbsp;<U>Aggregation
of Shares</U>. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Shares is decreased
by a consolidation, combination, reverse stock split or reclassification of Shares or other similar event, then, on the effective date
thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding Shares, and the Exercise
Price shall be proportionately increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.3&nbsp;<U>Replacement
of Securities upon Reorganization, etc. </U>In case of any reclassification or reorganization of the outstanding Shares other than a change
covered by Section 6.1.1 or 6.1.2 hereof or that solely affects the par value of such Shares, or in the case of any merger or consolidation
of the Company with or into another corporation (other than a merger or consolidation in which the Company is the continuing corporation
and that does not result in any reclassification or reorganization of the outstanding Shares), or in the case of any sale or conveyance
to another corporation or entity of the property of the Company as an entirety or substantially as an entirety in connection with which
the Company is dissolved, the Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise
of this Purchase Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder (as adjusted pursuant
to this Section 6.1.3) immediately prior to such event, the kind and amount of shares of stock or other securities or property (including
cash) receivable upon such reclassification, reorganization, share reconstruction or amalgamation, or consolidation, or upon a dissolution
following any such sale or transfer, by a Holder of the number of Shares of the Company obtainable upon exercise of this Purchase Warrant
immediately prior to such event; and if any reclassification also results in a change in Shares covered by Section 6.1.1 or 6.1.2, then
such adjustment shall be made pursuant to Sections 6.1.1, 6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly
apply to successive reclassifications, reorganizations, share reconstructions or amalgamations, or consolidations, sales or other transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1.4&nbsp;<U>Changes
in Form of Purchase Warrant</U>. This form of Purchase Warrant need not be changed because of any change pursuant to this Section 6.1,
and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Shares as are stated in the Purchase
Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new Purchase Warrants reflecting
a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the Commencement Date or the
computation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.2&nbsp;<U>Substitute
Purchase Warrant</U>. In case of any merger or consolidation of the Company with or into another corporation (other than a merger or consolidation
which does not result in any reclassification or change of the outstanding Shares), the corporation formed by such merger or consolidation
shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder of each Purchase Warrant then outstanding
or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant) to receive, upon exercise
of such Purchase Warrant, the kind and amount of shares of stock and other securities and property receivable upon such merger or consolidation,
by a holder of the number of Shares of the Company for which such Purchase Warrant might have been exercised immediately prior to such
merger or consolidation, sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to
the adjustments provided for in this Section 6. The above provision of this Section shall similarly apply to successive mergers or consolidations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.3&nbsp;<U>Elimination
of Fractional Interests</U>. The Company shall not be required to issue certificates representing fractions of Shares upon the exercise
of the Purchase Warrant, nor shall it be required to issue scrip it being the intent of the parties that all fractional interests shall
be eliminated by paying cash in lieu of any fractional interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">7.&nbsp;<U>Reservation
and Listing</U>. The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose of issuance
upon exercise of the Purchase Warrants, such number of Shares or other securities, properties or rights as shall be issuable upon the
exercise thereof. The Company covenants and agrees that, upon exercise of the Purchase Warrants and payment of the Exercise Price therefor,
in accordance with the terms hereby, all Shares and other securities issuable upon such exercise shall be duly and validly issued, fully
paid and non-assessable and not subject to preemptive rights of any shareholder. As long as the Purchase Warrants shall be outstanding,
the Company shall use its commercially reasonable efforts to cause all Shares issuable upon exercise of the Purchase Warrants to be listed
(subject to official notice of issuance) on all national securities exchanges (or, if applicable, on the OTC Markets or any successor
trading market) on which the Shares issued to the public in the Offering may then be listed and/or quoted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">8.&nbsp;<U>Certain
Notice Requirements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1&nbsp;<U>Holder&rsquo;s
Right to Receive Notice</U>. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to receive
notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the
Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the events described in
Section 8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event at least ten (10) days
prior to the date fixed as a record date or the date of closing the transfer books for the determination of the shareholders entitled
to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution,
liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the case
may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other shareholders
of the Company at the same time and in the same manner that such notice is given to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.2&nbsp;<U>Events
Requiring Notice</U>. The Company shall be required to give the notice described in this Section 8 upon one or more of the following events:
(i) if the Company shall take a record of the holders of its Shares for the purpose of entitling them to receive a dividend or distribution
payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings, as indicated by the
accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer to all the holders of
its Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable for shares of capital
stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or winding up of the
Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale of all or substantially all
of its property, assets and business shall be proposed. Failure to give such notice shall not invalidate any such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.3&nbsp;<U>Notice
of Change in Exercise Price</U>. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to Section
6 hereof, send notice to the Holders of such event and change (&ldquo;<B>Price Notice</B>&rdquo;). The Price Notice shall describe the
event causing the change and the method of calculating same and shall be certified as being true and accurate by the Company&rsquo;s Principal
Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.4&nbsp;<U>Transmittal
of Notices</U>. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall be
deemed to have been duly made when hand delivered, or mailed by express mail or private courier service: (i) if to the registered Holder
of the Purchase Warrant, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company, to following address
or to such other address as the Company may designate by notice to the Holders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If to the Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">[_____]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: [___________________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: [________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Amesite Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">607 Shelby St. Ste. 700, PMB 214</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Detroit, MI 48266</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attn: Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: ams@amesite.io</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">9.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.1&nbsp;<U>Amendments</U>.
The Company and Laidlaw may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders in
order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any other
provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and Laidlaw may
deem necessary or desirable and that the Company and Laidlaw deem shall not adversely affect the interest of the Holders. All other modifications
or amendments shall require the written consent of and be signed by the party against whom enforcement of the modification or amendment
is sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.2&nbsp;<U>Headings</U>.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Purchase Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.3.&nbsp;<U>Entire
Agreement</U>. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection with
this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and supersedes
all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.4&nbsp;<U>Binding
Effect</U>. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their
respective successors, assigns and legal representatives, and no other person shall have or be construed to have any legal or equitable
right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.5&nbsp;<U>Governing
Law; Submission to Jurisdiction; Trial by Jury</U>. This Purchase Warrant shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any
action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought and enforced in
the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. The Company and the Holder agree that the prevailing party(ies) in any such action
shall be entitled to recover from the other party(ies) all of its reasonable attorneys&rsquo; fees and expenses relating to such action
or proceeding and/or incurred in connection with the preparation therefor. The Company (on its behalf and, to the extent permitted by
applicable law, on behalf of its stockholders and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted
by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.6&nbsp;<U>Waiver,
etc</U>. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not be deemed
or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision hereof
or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of any breach,
non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in a written instrument
executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance
or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.7&nbsp;<U>Execution
in Counterparts</U>. This Purchase Warrant may be executed in one or more counterparts, and by the different parties hereto in separate
counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement,
and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of the other
parties hereto. Such counterparts may be delivered by facsimile transmission or other electronic transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.8&nbsp;<U>Exchange
Agreement</U>. As a condition of the Holder&rsquo;s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any time prior
to the complete exercise of this Purchase Warrant by Holder, if the Company and Laidlaw enter into an agreement (&ldquo;<B>Exchange Agreement</B>&rdquo;)
pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or a combination of both,
then Holder shall agree to such exchange and become a party to the Exchange Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[<I>Signature Page Follows</I>]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Purchase Warrant to be signed by its duly authorized officer as of the 7th day of January, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMESITE INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ann Marie Sastry</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">[<I>Form to be used to exercise Purchase Warrant</I>]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Date:<U STYLE="text-decoration: none"> __________</U>,
202__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The undersigned
hereby elects irrevocably to exercise the Purchase Warrant for shares of Common Stock (the &ldquo;<B>Shares</B>&rdquo;) of Amesite Inc.,
a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and hereby makes payment of $_________________ (at the rate of $_____ per Share)
in payment of the Exercise Price pursuant thereto. Please issue the Shares as to which this Purchase Warrant is exercised in accordance
with the instructions given below and, if applicable, a new Purchase Warrant representing the number of Shares for which this Purchase
Warrant has not been exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The undersigned
hereby elects irrevocably to convert its right to purchase Shares of the Company under the Purchase Warrant for Shares, as determined
in accordance with the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD STYLE="text-align: center; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="text-decoration: none">Y(A-B)</U></FONT></TD>
    <TD STYLE="width: 66%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where,</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of Shares to be issued to Holder;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The number of Shares for which the Purchase Warrant is being exercised;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair market value of one Share which is equal to $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>;
and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Exercise Price which is equal to $<U> </U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The undersigned
agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement with respect
to the calculation shall be resolved by the Company in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Please issue the
Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a new Purchase
Warrant representing the number of Shares for which this Purchase Warrant has not been converted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Signature________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">INSTRUCTIONS FOR REGISTRATION OF SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:___________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">(Print in Block Letters)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 81pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 33%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTICE: The signature to this form must correspond
with the name as written upon the face of the Purchase Warrant without alteration or enlargement or any change whatsoever, and must be
guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national securities
exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>(To assign the foregoing
Purchase Warrant, execute this form and supply required information. Do not use this form to purchase Shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing
Purchase Warrant and all rights evidenced thereby with respect to _____________ Shares issuable thereunder are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt double">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt double">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature: _____________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address: _____________________</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ea022707301ex5-1_amesite.htm
<DESCRIPTION>OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 60%"><IMG SRC="ex5-1_001.jpg" ALT=""></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sheppard,
    Mullin, Richter &amp; Hampton LLP</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30
    Rockefeller Plaza</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York 10112-0015</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212.653.8700
    main</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212.653.8701
    fax</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.sheppardmullin.com</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
10, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>VIA
ELECTRONIC MAIL</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amesite
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">607
Shelby Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suite
700 PMB 214</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Detroit,
Michigan 48226</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Prospectus
    Supplement to Shelf Registration Statement on Form S-3 (File No. 333-<FONT STYLE="background-color: white">260666)</FONT></U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Amesite Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;) in connection with the preparation and
filing with the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) pursuant to Rule 424(b) of the Securities Act
of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), of a prospectus supplement, dated January 7, 2025, to the prospectus,
initially filed with the Commission on November 5, 2024, and declared effective by the Commission on December 18, 2024. The Company has
requested our opinion with respect to certain matters in connection with the offering for sale by the Company of 1,201,667 shares (&ldquo;<B>Shares</B>&rdquo;)
of the Company&rsquo;s common stock, par value $0.0001 per share (&ldquo;<B>Common Stock</B>&rdquo;), pursuant to the Registration Statement
(as defined below) and the Prospectus (as defined below). Unless defined herein, capitalized terms have the meanings given to them in
the Underwriting Agreement (the &ldquo;<B>Underwriting Agreement</B>&rdquo;) dated January 7, 2025 between the Company and Laidlaw &amp;
Company (UK) Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion is being furnished in accordance with the requirements of Item 601(b)(5)(i) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have reviewed and relied upon the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Registration Statement on Form S-3 (File No. 333-<FONT STYLE="background-color: white">282999</FONT>) filed with the Commission which
    was declared effective on December 18, 2024, under the Securities Act (including any documents incorporated by reference therein,
    the &ldquo;<B>Registration Statement</B>,&rdquo; and the related prospectus included in such Registration Statement (including any
    documents incorporated by reference therein, the &ldquo;<B>Base Prospectus</B>&rdquo;));</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    final prospectus supplement, which includes the Base Prospectus, filed January 7, 2025 pursuant to Rule 424(b) under the Securities
    Act (the &ldquo;<B>Prospectus</B>&rdquo;);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Underwriting Agreement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    resolutions of the Board of Directors of the Company, adopted on December 24, 2024 and the resolutions of the Pricing Committee of
    the Board of Directors of the Company adopted on January 6, 2025 authorizing/ratifying the execution and delivery of the
    Underwriting Agreement, the issuance and sale of the Shares, the preparation and filing of the Prospectus, and other actions with
    regard thereto; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
    other documents, records, certificates, memoranda and other instruments as we deem necessary as a basis for this opinion.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our examination, we have assumed the genuineness of all signatures, including endorsements, the legal capacity and competency of all
natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents
submitted to us as facsimile, electronic, certified or photocopy, and the authenticity of the originals of such copies. As to any facts
relevant to the opinions stated herein that we did not independently establish or verify, we have relied upon statements and representations
of officers and other representatives of the Company and others and of public officials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing and subject to the qualifications and assumptions stated herein, we are of the opinion that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
    (i)&nbsp;execution and delivery by the Company of the Underwriting Agreement, (ii)&nbsp;effectiveness of the Registration Statement,
    (iii)&nbsp;issuance of the Shares pursuant to the terms of the Underwriting Agreement, and (iv)&nbsp;receipt by the Company of the
    consideration for the Shares specified in the resolutions, the Shares will be duly authorized for issuance and, when issued, delivered
    and paid for in accordance with the terms of the Underwriting Agreement, will be validly issued, fully paid and non-assessable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion letter as an exhibit to the Company&rsquo;s Current Report on Form 8-K being filed on the
date hereof and incorporated by reference into the Registration Statement. We also hereby consent to the reference to our firm under
the caption &ldquo;Legal Matters&rdquo; in the Prospectus. In giving this consent, we do not admit that we are within the category of
persons whose consent is required under Section 7 of the Securities Act, the rules and regulations of the Commission promulgated thereunder
or Item 509 of Regulation S-K. We express no opinion as to matters governed by any laws other than the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
disclaim any obligation to advise you of facts, circumstances, events or developments that hereafter may be brought to our attention
and that may alter, affect or modify the opinion expressed herein. Our opinion is expressly limited to the matters set forth above and
we render no opinion, whether by implication or otherwise, as to any other matters relating to the Company or the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%">Respectfully submitted,  </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">/s/ Sheppard, Mullin, Richter &amp; Hampton LLP</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">SHEPPARD, MULLIN, RICHTER &amp; HAMPTON LLP</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ea022707301ex99-1_amesite.htm
<DESCRIPTION>PRESS RELEASE DATED JANUARY 6, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amesite
Announces Proposed Public Offering </B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">DETROIT,&nbsp;January
06, 2025&nbsp;/PRNewswire/ --&nbsp;Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing
of B2C and B2B AI-driven solutions, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">today announced
that&nbsp;it intends to offer and sell shares of its common stock (or pre-funded warrants in lieu thereof) in a &ldquo;best efforts&rdquo;&nbsp;underwritten
public offering. The proposed offering is subject to market and other conditions and there can be no assurance as to whether or when
the offering may be completed, or as to the actual size or terms of the offering.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
&amp; Company (UK) Ltd. and Craft Capital Management LLC are acting as joint book-running managers for the offering.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to use the net proceeds from the offering for general corporate purposes, capital expenditures, working capital and general
and administrative expenses.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
shelf registration statement on Form S-3 (Registration No. 333-282999) relating to the public offering of the securities described above
was previously filed with the Securities and Exchange Commission (SEC) and declared effective on December 18, 2024. A preliminary prospectus
supplement and accompanying prospectus relating to the proposed underwritten public offering will be filed with the SEC and will be available
on the SEC&rsquo;s website at www.sec.gov. Copies of the preliminary prospectus supplement (when available) and accompanying prospectus
relating to the offering may be obtained from Laidlaw &amp; Company (UK) Ltd., 521 Fifth Ave., 12<SUP>th</SUP>&nbsp;Floor, New York,
NY 10175, Attention: Syndicate Dept.; email: syndicate@laidlawltd.com.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or other jurisdiction. Any offer, if at all, will be made only by means
of the prospectus supplement and accompanying prospectus forming a part of the effective registration statement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Amesite Inc.</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Amesite
Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions.
Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional
needs. NurseMagic&trade;, the company&rsquo;s mobile app for health and care professionals, streamlines creation of nursing notes and
documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling
challenging workplace situations.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward
Looking Statements</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934,
as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company&rsquo;s anticipated public
offering, the Company&rsquo;s planned online machine learning platform, the Company&rsquo;s business plans, any future commercialization of the Company&rsquo;s
online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements
that are predictive in nature and depend upon or refer to future events or conditions, and include words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;should,&rdquo; &ldquo;would,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend,&rdquo; &ldquo;look forward,&rdquo;
and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking
statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future
performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and
its planned platform are set forth in the Company&rsquo;s &filig;lings with the SEC. Except as required by applicable law, the Company undertakes
no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result
of new information, future events or otherwise.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations Contact</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MJ
Clyburn</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TraDigital
IR</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">clyburn@tradigitalir.com</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>ea022707301ex99-2_amesite.htm
<DESCRIPTION>PRESS RELEASE DATED JANUARY 7, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Amesite Announces Pricing of Public Offering </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white">DETROIT,&nbsp;January 7, 2025&nbsp;/PRNewswire/
--&nbsp;Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven
solutions, </FONT>today announced the pricing of its &ldquo;best efforts&rdquo; underwritten public offering of 1,201,667 shares of its
common stock at a public offering price of $3.00 per share, before underwriting discounts and commissions, for an aggregate offering of
approximately $3.6 million. Certain officers and directors of the Company are participating in the offering for aggregate subscriptions
of approximately $1.26 million. The offering is expected to close on January 8, 2025, subject to the satisfaction of customary closing
conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Laidlaw &amp; Company (UK) Ltd. and Craft Capital Management LLC are
acting as joint book-running managers for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The Company intends to use the net proceeds from the offering for general
corporate purposes, capital expenditures, working capital and general and administrative expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">A shelf registration statement on Form S-3 (Registration No. 333-282999)
relating to the public offering of the securities described above was previously filed with the Securities and Exchange Commission (SEC)
and declared effective on December 18, 2024. A preliminary prospectus supplement and accompanying prospectus relating to the underwritten
public offering was filed with the SEC and are available on the SEC&rsquo;s website at www.sec.gov. Copies of the preliminary prospectus
supplement and accompanying prospectus relating to the offering may be obtained from Laidlaw &amp; Company (UK) Ltd., 521 Fifth Ave.,
12<SUP>th</SUP>&nbsp;Floor, New York, NY 10175, Attention: Syndicate Dept.; email: syndicate@laidlawltd.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">This press release shall not constitute an offer to sell or the solicitation
of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such
offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other
jurisdiction. Any offer, if at all, will be made only by means of the prospectus supplement and accompanying prospectus forming a part
of the effective registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>About Amesite Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="background-color: white">Amesite Inc. (Nasdaq: AMST) is
a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions. Leveraging its proprietary
AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic&trade;, the
company&rsquo;s mobile app for health and care professionals, streamlines creation of nursing notes and documentation tasks, enhances
patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">This communication contains forward-looking statements (including within
the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended)
concerning the Company, the Company&rsquo;s anticipated public offering, the Company&rsquo;s planned online machine learning platform, the Company&rsquo;s
business plans, any future commercialization of the Company&rsquo;s online learning solutions, potential customers, business objectives and
other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future
events or conditions, and include words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;would,&rdquo; &ldquo;expect,&rdquo;
&ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend,&rdquo; &ldquo;look forward,&rdquo; and other similar expressions among others. Statements
that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions
that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from
those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company&rsquo;s &filig;lings
with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement,
or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>Investor Relations Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">MJ Clyburn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">TraDigital IR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">clyburn@tradigitalir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>7
<FILENAME>ea022707301ex99-3_amesite.htm
<DESCRIPTION>PRESS RELEASE DATED JANUARY 8, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.3</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amesite
Announces Closing of Public Offering </B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">DETROIT,&nbsp;January
8, 2025&nbsp;/PRNewswire/ --&nbsp;Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing
of B2C and B2B AI-driven solutions, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">today announced
the closing of its &ldquo;best efforts&rdquo; underwritten public offering of 1,201,667 shares of its common stock at a public offering
price of $3.00 per share, before underwriting discounts and commissions, for an aggregate offering of approximately $3.6 million. Certain
officers and directors of the Company participated in the offering for aggregate subscriptions of approximately $1.26 million.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laidlaw
&amp; Company (UK) Ltd. and Craft Capital Management LLC acted as joint book-running managers for the offering.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to use the net proceeds from the offering for general corporate purposes, capital expenditures, working capital and general
and administrative expenses.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
shelf registration statement on Form S-3 (Registration No. 333-282999) relating to the public offering of the securities described above
was previously filed with the Securities and Exchange Commission (SEC) and declared effective on December 18, 2024. A preliminary prospectus
supplement and accompanying prospectus relating to the underwritten public offering was filed with the SEC and are available on the SEC&rsquo;s
website at www.sec.gov. Copies of the preliminary prospectus supplement and accompanying prospectus relating to the offering may be obtained
from Laidlaw &amp; Company (UK) Ltd., 521 Fifth Ave., 12<SUP>th</SUP>&nbsp;Floor, New York, NY 10175, Attention: Syndicate Dept.; email:
syndicate@laidlawltd.com.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or other jurisdiction. Any offer, if at all, will be made only by means
of the prospectus supplement and accompanying prospectus forming a part of the effective registration statement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Amesite Inc.</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Amesite
Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions.
Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional
needs. NurseMagic&trade;, the company&rsquo;s mobile app for health and care professionals, streamlines creation of nursing notes and
documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling
challenging workplace situations.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward
Looking Statements</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934,
as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company&rsquo;s anticipated public
offering, the Company&rsquo;s planned online machine learning platform, the Company&rsquo;s business plans, any future commercialization of the Company&rsquo;s
online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements
that are predictive in nature and depend upon or refer to future events or conditions, and include words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;should,&rdquo; &ldquo;would,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend,&rdquo; &ldquo;look forward,&rdquo;
and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking
statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future
performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and
its planned platform are set forth in the Company&rsquo;s filings with the SEC. Except as required by applicable law, the Company undertakes
no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result
of new information, future events or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MJ
Clyburn</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TraDigital
IR</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">clyburn@tradigitalir.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ; /H# 2(  A$! Q$!_\0
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M^_:M^ _BKQ?=W?V#2?#VF?$GPY)J>O:AM*F/0=MRO_"0N3E@WAK[0JY91D,
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M8O@A^SK^W-^WOK6J7OB?Q-K.@>+_ (D>#OAUXD\=Y8#7?&FMGP!\./%7B?\
MX1]O$>N;1XJ/C#P< Y'#8PVT_!K#Y;Q!GF7XO-:KRC(</#$>VP]&,9SIU54G
M&//4:PU.HK.RE4^&T_<BFS!^.&*Q/#V5XW"Y5'^V:M25-PG.\5*#4965N9Q;
M?3F6CZZ']U?@3_@H]^PA\4=<M/"_@;]K;X"ZOKNK7;6&F:%'\2_!^G:OK5\
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MZ\5][E/B1Q;DN50RW"XZDJ-/EE#FPV'G*$X7<)0G.E*<7%KW6GS13=I*[O\
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MW6[-:UO#SA/,,9G.+Q.60J3SA16(O)MV5MFU=6<5:SV5KZL_CV\-_P#!"?\
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M_AYX*\.6:)X>\'^"O#ND^&/"V@H]U?SLFC>'M&M+/2-,1III9&2RLX%+-R"
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*[?I_]>M"B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>vde0-20250107.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qA5s7xRiXgen8uKa3EsWaGM6aPtzplyKZlBtmd4benaDyUmQZroqi0MT4YWcQ4M -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:VDE0="http://amesite.com/20250107" elementFormDefault="qualified" targetNamespace="http://amesite.com/20250107">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://amesite.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="vde0-20250107_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="vde0-20250107_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>vde0-20250107_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>vde0-20250107_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://amesite.com/role/Cover" xlink:href="vde0-20250107.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://amesite.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45832829127424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 07, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  07,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Amesite Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001807166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-3431718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">607 Shelby Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 700 PMB 214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Detroit<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">48226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">876-8130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMST<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M:O^[P?[&R*PXJZ^DP9-_<1D!QYEK7\#/UU*:]QM[_"]_O9G\"U!+ P04
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " "E@"I:!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( *6 *EHT[CY%[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( *6 *EJ97)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
MI8 J6DAYZ+N*!   R1$  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( *6 *EJ?H!OPL0(  .(,   -
M          "  <T,  !X;"]S='EL97,N>&UL4$L! A0#%     @ I8 J6I>*
MNQS     $P(   L              ( !J0\  %]R96QS+RYR96QS4$L! A0#
M%     @ I8 J6JK$(A8S 0  (@(   \              ( !DA   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( *6 *EHD'INBK0   /@!   :
M      "  ?(1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( *6 *EIED'F2&0$  ,\#   3              "  =<2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "$4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0227073-8k_amesite.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amesite.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0227073-8k_amesite.htm">ea0227073-8k_amesite.htm</File>
    <File>vde0-20250107.xsd</File>
    <File>vde0-20250107_lab.xml</File>
    <File>vde0-20250107_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0227073-8k_amesite.htm": {
   "nsprefix": "VDE0",
   "nsuri": "http://amesite.com/20250107",
   "dts": {
    "inline": {
     "local": [
      "ea0227073-8k_amesite.htm"
     ]
    },
    "schema": {
     "local": [
      "vde0-20250107.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "vde0-20250107_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vde0-20250107_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://amesite.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-01-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0227073-8k_amesite.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-01-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0227073-8k_amesite.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://amesite.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001213900-25-002639-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-002639-xbrl.zip
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M7L[#A;!SJU[<EBO2[YU)/BLWUY]_/;0<H%V0@'5X'@V^4F& 0+Z'1.S,@*7
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M)W$ZQ2J12J525+:51J,!Z/%4%IGP8$PU*(HE \B<^"2 '<=/.:1PY%$ECK[
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M!W]8_S"<N[$P.20\ #LE^DF.D@0SN2J(WF-L>X^AY]X%+B8\9\4\X67BCVA
MHQLYQ&*$YU7!A9VAUQ;=BQB:[J$/GBF_ S&J:A;0EV/Z&$3!.%BV+@1'>'6
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MB:],$=Z9B. 9C[RZOR!]9FVHWJH@BZ*&:[+8U&717#%1KK(Y*//76;&T<<N
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M;S+.[_BT#Y4#_K!!(KC3/K+/>V>?ETY3&;P!8B7M3$V_<U7E'BGPCV%%[3B
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MLXP<9297\2?5?B[D<#G;-@0U=VAC!^PPVS+D::MN1%Z*40-[$,1IX!;A0O'
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MEXO^C(8T^>F_IV+HDZ#6=")1&A/3ET%"J?/?P!K[W&[S>['# HWICB^*5S+
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M9#A/=J=A3,Y-3K!;*FDPIBC3 V%[9&3O9A7T;LQ71K!.U@<"/ZTD.HN-X78
M&WB1ZH9_6&)6!0>C'9><.\V0GQM*F-.310_5',1*)IXW0D)DG5@VVY.@(]I
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MACP(;;/OW;/T^M39&09#-AK9A[-W73:BW1@(!6#WD?2WVY=S=O<BN V?35+
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M-3>"-")^"(8R8:AOJ$<46R<LS8KTVER^TU$];6)2-']@5H!JE'(2YEO>4,J
M+O',G(T*51N(T:4;O4?<,!BL8I4FP F,%!I!'P6S%VQ%<E)@R,,LKE04CUO
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M[(]+IB4H?^\JI0^&^84?';9/NF@%(DZNX+NEML"K-9/&%/AO;.J"PK@)?5B
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M)9>JXU0*P%@<:(%K7$8U+A/71UX0>ZWR "R'<"/_SH K@Q3NIB#!P+G!S'W
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M?HIG:^WI>K"[ /8>YGFPKZYR9Z;Z;>73-TK3SWG97T&!E32%+)[#\C0J59
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MO)NE!B>B+EIR:X(D7;#ASR.WD:!:P+AAAF1UL]LMS)(AC$S8PMP AAAC/*,
MAB-$66[>YW26=%$86Z!E@'QZSP5KQD2! 0X @4T$-XC,7>-D[J%Q*15F>LS
M'=+LH!W;V*P;V/UF<*UELWQR).-(YPIS$#N'\"_#K9]/Z4:(T*;A>K1;@>)"
MZ-Q>ESSP?66JQW<M45FQ<XA)T-JW4\/<5$9D.L7T9DFJ"A.,SU%X*4UD'YS4
MBV6\JRZM@00\8]8&9LNY:X9C$!QSQ?9TG01FV!=..#9&GMP(;P9,D3CB\$S%
MQLB94]:$E3#T9+02R2LC,&9-?FM7.*Q?+.5$%CJ)VIQ-Q6P-$^Q<2JP[']-%
MED3Y.>.#J/B]90@NWUAV4^ A$UZDT(0&@B1*EH^?KJ,+'QX2Z0*>HP1LUZ5O
M()TH].C K""7Z63G9JZR&0S(1<(CREC^?J)P%B6<LP$LX"Q"<1<%FE U,RL2
M"HWK0N.*C-T,#J<3Y<Q7EUZB)(R390\$L1(9L./,X;W-XU#)!W9ZZ8Q7(QG/
M29$;645.9RZ:2@RX7DE*!P  !XC:TGZ4/7:T9P*3KFJ22KIGV6<M0V *:H$W
M08$L'N6VE%#9J#!M!KW?Q^&<RD:0+'7)F=VV@$2S)Q6+@QAI %0:$FZJPF)!
MC,WUO,(!%\'%ATJ+YY;/$\?8?BA*L+$4[%@E.$S"#)/R+>]^(,B0^VO'L0CT
MX:=9$DVCL;6/U-UDD3SGGG3T("_G$\R>B$?X+JZK)B;E2-H),"OB9R!/YZ1'
MB>O^\CPE#IBE<>X)IOJXD^H6JD1XK2;\QT^-XE[RG&4V2W +%=S*8YB#*9&)
MUM7VQ'>UN?4A[+.E4D!G"DN_$(N-TQSV<ARK:-8!QC13&#HI%R^"%$?:Q;1F
MJGZT6YZN@?5+0$M+PJM<*W5&TF USESDCGX"HRW([8AJ:W(!/ /5+Y(RX?*>
MJTP4P4DXE2H4!FS8. *XW;H$83%/4>)?MVJ4]<C.1&>E1'4M3S;;"@H**'<Q
MG%G>"6C+.%V4W*&5JQ-8IE5]%Z(;RKV9P_8 $HI0+%..!((_B.TIU_?U1<1R
MD$NM5D-T=1'R3HH"(4>#KQ&G &$>K"D;3VW"KQS9JXNC(.#K1-%*/ZC)\85#
MC?4O HZ+2[R)#U0T0:?;7]5L_LHZK==._W<]."@FFRZ!RK.5>EI\+8H$I[C8
MT%3\UQ?(-/W5)6K&@9(#C.)! U&?+S%,.A51TD#2(3&(PLIAS+^I9($FFN=<
M5:OLJ*Y?:[4PR\T9$0@^-9QHB1AF5A!E7"DIS]$>0B(TA7WDNE*.X 9->_@K
MBHS_!J6MP"]\OJE1 <?X&QE!<(M\@"(#OY(1!+5\ *:\^F(&4.:QS1P@2M!B
MR/LE4CXK(_@.2(,A;,O42-ER.72DZHZ_G:C!Z]W$-&DFN0Z%E>M:1V-'C[_&
M(/!M7*>.!;1;+S"68#D/J&=7WEDED;V&:;ET^8"T^)LXY'=^^-Y+OO>='[[W
M^TG.*-1;HY2M, 5LH^*.8J_?88JB\IG/<^H]>FZ()O"\!5_B;'>,/ LU7L1^
M!2MDMY4R1KFUDR#_-<XY*9?FF$F6: KBOC&6R40LQE21\>$P,MQYJ]ONI^,%
M8@<4EGU=W,LF?<O65[4[N41I[Y2Y,LGG&(VC.8><872LC;@TIFGC41/KH0SA
M>$B(#$TX;VI\K%J?4X'$WTJ.#5<=59,)QB8S_,Y%CAOO#(YU0%^"8+2.PU6O
M9O%A(&P2.MG@#^Q0MD\UH+-<?86%6/P*_]+8T)D^6G6]\DVLRMS4%,!'!==<
M.1DSG*Z%?ZD[$[$HXO,8A5P0NV"'"FT[B\,"#YD%WAR;=DNO8YE<0U)O=91F
M%'A.,@\%';W;8C5$:L9JAV0S=@KZR@+%/4NR7Y3-1+Q!#4Q*&J 9#OU<VDI6
M-N.!\J42JO%FEI-[GM1E^B0)A43/6/[<AD)@:;@".!D7%#62W0RM^EG5R;@,
MM6O:YFZ++!GPA$RBA.)S.UJ%'$N$.5O$&4'(5K7LS_O4J8"AZY$"\'1U&WG5
M(X$ZA*'&PH5JQ\"*@'ME$:R;T,%(E)-#NAUMC*V^KT\2KC-*FN'-;3U"A&OA
M2J^13_V8EN"1?^X'0-3Q.!7GJ<FHP B&><%F@J4<SP39<NP^65CUG3=.,T1N
MFE!P,*=LS,)9"E?<1&$U0JJWC#7ZXO12,\>FL ++#L> 2_&\D*G?G<1H^S71
MN;Z"B39KC7F\9$%K+(S^2C5*-:!N3#&&+2S$%V24%F<>+ N-%%2HZ;1"7FP]
MJ*_&2IDYY!?W\,WA]M:7CB#(<7$44C3^4:%:5^&=7% @,EOIJ[3NZHA&QB%-
M%Y5$R:KDNM^-8*.8$Q44$NXISB;PP21>754#HDL)5EC5>1'SOK[M'YYT-]NM
M066=QMHJ+G+24\F,BFE#'?19@#;!N\CY*S0#Z?ESY(*+Q%A>92]I?2.=J52*
MNT>HF5:H$F8H!.+P9$,Y'4ZG,LS,[(2CYZJB\BN[*I!Y)%X4025L ID_.S :
M?(;>]:?/Y .3])X82<^U!+1;CHFL7L(CU1"=6*DG2?C"B4%U0]R3Y5&N!Q@G
M$?D2S<(8ZM1@A</[@S/UO7N^/AXA>-(QT4]5:*Q2XIQ+-VFC7-)6O*IVL=<-
M@&3(68K4]8#N>^N/-?)@F9L1B==!3'>HR?,3EJ2/BS6YIFB)NF0]21]MO&<3
MTIMJLC=8J.;0/JK(7GM1.TJ>08&.>\10'5#[@T5NI;*Z%;@F5R=HB>[,,->.
MG66"K]PRJGR;.^$ H"\V40]>K^J*FC?P@^F<[P8)@>&E2+U?8E8E<_9RW);\
MP**=ZC#!$2B8T\@&(GCBB2-AZ"@N6N:D\77!HE"ECU,*42I%]IB<W-)Z$$1G
M1:)1FQWV+G%="KD4P$:5.\1?;0RWK*?0(?*-J(QYB7RU%G)RCZ- /0N+\W1"
M%XT;__? ^/33.HV<O:%6+Q]=6;,)\^V>(@6Y9%'Y4C6\HM-[+ -#>]TBX";=
MFF5;N'@5GB43KU!B.8X,[(E8#K>1($*2R./8B<R[TF$AFS?,S!NB5T"8JZYL
M+;TB.!2X\&/AW" \#* @_Q0B;&E,3&V0!)D9)"3%*.V.BC;EZN%:8N(2N/F2
MT$JG9F]'!SBZ\A!GEQ:P:S9[TFQ:P#H PI/B-6+V@0%Q=X(\CEKU$ T&6,9%
ME"XP@!3/Z3@T+4M,T"M.S$D +(15AB4K'4J*DU!-8%?#CL\N>2,09:QZS&9H
M!"3]V!46IVB6R$V;#U%AI1$*WUPNW\,M]-"$SU3HJMUBPM+K71*N2>'AH9-X
M2<GA3:F84I= =#<MEJ^9FBTD^9IN.T7*[7VT^KY^#3Q+'):8<%J8IB$<Z(Q*
M>L/VN%>SVX,I9YG#/3-L<[$;*_RD<=\KY.2<$JH>//(E!TT/EO2 ?RDO-/OZ
M M0$AI257H(E7)MD"Z-MFFX\V9MJ6*^S*M(#EX7@W462ZIU?6L_LI45.:!W7
M.CC'WCO5G5MF@;>'&/;&B3P+3#%LM,6HJ]I>#=Y'[0-NMZ8JBO.RRLWE)8P/
MM5.Z.VV"AIJ 'BOQ>S:)A@-;3=8#</HHG#I])KSP2U2!2#)S[YETQ(*\]A6#
M3DYTEG#_!7&_ S(*&M!QX4?)OQ<)86[=3"S^]8)"5H%O H-!%&6A2 :EY5*N
M.=NB*"+4) ,9;9M?[9@R%/@PVR\D>9T&0U$=KC5 !<<?Y,9M7?].RA+ *$TF
M9I&FJ,QW]B/?>7#A37S)3W[XDDN^Y"<_?,GWDJ0YC_NID\<-HU?;'.C@SCYY
M81Y2%*W,_-2)HCU&#0U#BOU.'0-;GHLO3]2'1=9U@OQVG%9P-VKB5].ET4^7
M,)*6\<3+M2M/4XAD1S=_N[8#!0IC8[S0XK@QVX(R#H4FJGVE1#+5%PH,GYV%
MC260JB6L:GOZ250\:@B>SEQ;S,J@1%?F20.OM-4-"UJIW(VQJ@,+]3A61\/$
M[MF#.QPV&N4 A(5V:X^;;XVI7RFEG;-#AW,PRC+@U-;<\6RRJ(295%V.FX2_
MI@6VS,/0E+$63&>+(HJ---3038O<)M,E!F O-EY+IEKXH>PXE(#JCH-85=PV
M:R5RMV#X]$YO )8V@ZZ6X6I/B5<FSWI.%2OQ^2*VQD8/42YF,A=M.O.$HGRP
M.2D>4#)\\P<*N1<I45)VG4QFG9]^9^&$=W]G/MLT--\US6,?5(*)S/S,N1H=
M3-!M4.H0B,1[:%FO4_Y ^[%J7JCEU]=48;#^BH8FO]4>T$IWMV7;5Q[235B<
MWX=RZ-_-, ![Z>PFX;K=VH^(.T]R4''F,7#DTWFNFY-UG( ^BBLQ96/9C^9*
M1$[LLY.G\VQSAV,F.J6==I,V>=>EB,@86;AX([G)=# 1$-U"G[JA?28/$NB+
MN4-$1F'/HQEPR8S%*2Y>8)HU6DLA5G$6@X=80V\H1AABM+![&?O&SZY_IQB;
MRO)-CD+IE#A)A'9,;J$Y"67"!^2101K>MOI,5ZJ8:I.D;EE^!_3+_19D1R@W
M5]']B[J\B-KC=#;"CM?BZ81;/@^%QIF R5(ZCC&-P8HJ7T_1Y/5S>U-_*4F;
M]320M/[]IB0-NB=Q_D:2-F?H@9&T#?L]">>Q&NO&U^X]RCK>29AF9RJ)_BMD
M%!;CS0 )OI^88$)V I3I"&G+?5>+>#6D[)074@$G\J"OT?@Z[?& &P5'YF,I
MFFDJQ5*ELH\BBLRU:&D;E1 ):5))C<?'7<4L!.62XH2]HV0T0#?XB8<@DS##
M/TXS("Y>ZYJWI(9A;7=%S_N1NV99#K0W [-3AI8[24-6%T5D-]Z8K]^(]2:\
M<)0%@7\17BF*66Q8.9820!NW\3-+L-E52<3GP"YZ-@N+*Z[W[(;&EGZO">TB
MW/FN1&2*40XHO@@G7BFP1@M%78TPOIF9F:]QF0,VB9A6R]H=%8F[.G3S)FHG
M6G=;A=+1JK&R=$S4!P4%VZ+9)5%62R:6AV*ZJ&D*KP.CQ(CBN-WH\*][G;%-
M0@6W43$\/O@<):PBJIDN<V5+3?$U8J\(RS;2S&ZYFWZ,S5C7!0,$O-B0R)7F
MTVRG1+$=GIAB&!-/65<S%9^IF3Q5/F#T#4VCA"P6?(AL(U+C[= DKHLK=UC2
M<\FGYD(KT31[=.SJKJUY!U+H\JUXQ5&5#4R6XH;X_'/35>&>CLAZ+1OE"QT[
MAJ _W6HUI=)2U0(R.0_4$6[,C*E,:ZR)^=).]2F=#LN"!D9T8CSLE:""W$=4
M0,A??EZFD[R>4/(RI>154L%7.0Q#D[0FA%774+]OLH$-%-TC6LK)Y4TU^&IR
MPK2V'>4<\ECS2)!@YJC$V3!]3G2A.7W!"-DV1G0"8!($6?4FZ&P.5K61BF4T
MM'YS=6G#41M, O1;Y7!+4 D-80)B:E+2)/D,Y4D&I;(,$V3+QP&#L^<<%.I%
MP6IV@L,HJ1I>9\'#<)\IE86DN@[68XZ\%T/E^;P(&KPX)]MIZ%)1Q JR%2Z/
MP^&5#@=(QYCE35QR2:=POK X-FPA)?Z*NTBFNP?&*VNZ'ACK9]4!)OIB<A/1
MLR[L_MLE3XRV1KGS"V1(W5UMB>S(8JL%!1F"4P.P$99FN[?O T*;,EP+1'LJ
MKO(9#CSTZOZ?FW-%81#5#NE8W,M9#$=%D"O*JP]X<R%1N(4O*]+ZETF$'5]>
M(#&R]J4;BV:V@$/N1ST9X:Q6%&O8I(Y8&,Z_2!RR_6QKUQ+,"(^V))CCIVR2
MBMJM)@@K$IQ$2"^G&:ERQR&K7!K8FITU\,;D1J%U8Q53+"6NU'W8*R]6CG=[
M)IQ_E%XXXE!%&BK)04&=&,0(R*LBS -CMS<)GGGZ(WBF%#SS]$?PS/TEZ6>.
M9:Z'%?P2:W]ZFW&P,U!5'XD$0[B;<K9J"KR2: KT97SIN4T(X?(X.I;:<8R5
MS13&$%:]EM !+2F(#7-C*/"<?]6N-BZ-:"Q%.AV(DG$P$<$N.=)+UO6 ,:Q%
M,,0RQER1!P_-#,A]XRA<:-FJ;IR'PRS9Q?Q\T['YYF%VX=@3#R**2VBB)MD-
MSL?,Z&46TSZ'X=R)>,7X'*EYJ1;%>9I%_\5ND6)Q%?.LT^^,:IM+UC?;%&N,
M)C55\3M>)[@ZAX53SMG)=45+**LZ;O<XFMT(0:3*N%5(2(_QD&+SODH!\ITZ
MHT]=5?]2L\&J%XXG!E1U2/EV6LN9K"S.V.,0=DZP=3*K*H*?OTAIF"PS6O<+
M]E#$UR^ HB9&G>T$TT6,-IFYBB92IRS9 /T ,YDIH5I*ESDNKCGJNW,N^\PH
MUY9D!/)<RKUV\R#&0N52SZJ**%OHW0KCWYH\PG8'!V$^;J[?/58/8DPXF+1;
M:\ZJ*1,:RQ\X!6"%MM>I*S"R9B6<J*;_=0[:FZ3SFW1PXVD[&NX%'ZC:?J[3
M44PU,FX]C.R/Z_'3;-:UX"S49@A)'00Q:^C^%60T(:W(K!'W]V>8\3^+M/C^
MX6C;=\TX7UC&B9%H*DJHER3N[PG?<0\U6.>%$][!*KJNW"$]FY#43L3EP2CS
M*TA)#>;Z*E'P 7L<4B:QED-,N7"KA*?!15IHYU2NRSL9Q9H:!Y"IC[*_+/<Q
M%Q'EHXLN-M$]ADTK76*D7)REPR7_=#M.QW)F*QE6IV$V8FI9<IR =#SHN*E]
MY:;>95]3_3524 ZM9EH=-\%3:K:X.5C4-X#+@VYN"][)RJ>]^NA83PB;U!('
MK0G(]'FHNFA%+"!>+IVM;1=<?UUA&72%F2E4_GR+2VEC1J2S7 J7F$:_VS!$
MO/&DNHP348'EE:1:$%V"NG$N]\;56ZI[3'OX<S8E-VDX-DU91_UT2LU'R.69
MZ1(FFE/[16.T\Q(%7)J2Z:)CG*&2\,.4FIA4'*GQ;CU3<+?%$? 4;=*XC-C^
MA)%&&1DX_!+O8BZ@!*(KXTMKPAS9YP1[\M%'H*GD.B8#-T>/?T5_"<=\YQ4Y
MP (U5\88)VO@$O2Z*R4++LY657SONBTJFNPYV"XQQGDII90DNH%J[B KROVY
MW%D>'.=V2OY=<(3EB:G*Y[+JJC90TNV( 9 QD+'<G/+Y@OEXB;\P,6EW+#.:
MER!6<5FS*FU1[J]A$#* TS, I4"1=VI4#3Z-0L0SUR6O;-P?!C<[/  %7W:W
MVYK\IA46:)M\+[#BV31&T#"$J$Q9*$4V0I5A[7$^B7CXQ\IVRP!ES98T*S#%
MS_0B<SE89>ZTN7]XAPO(5=',[6'1QR#5,"R*N>J/T3:N3'XD"K7&#CQ6\ZB@
M2F 4*%#RDWO*";/8(N)82RY$H1DM(6V:9M61L=9:=>B.N;EUA0\.T3"U+MB8
M.F(BM7H6/@&HB-;]4(%.X/!C&L7AR/[-?GV7M))C)[M15,,Z4Y>N<T)[4PF5
M08.(T+XV[R,%Y:%("::(DQ\)AX%OP5M0WQ=9:,YR7KE?4+>+$E(*J0V\::\^
M_O[U.6I9YYU9GK\KR[:F06;0M.5[)M[#MR T<.^.K5_'GBL,L;K@%'K-_MT@
MDAK31$TD2+OUS 0PY2%; VHZT)3D0BRAPQ,Y]>5Y#GT#E8NVN[\:6<,>Y7:+
MAT85WY3:XRFTIY^+S# ;B<<+J2S$T5:FQ-+(&$I9'A6#)6@F;/)!B1E/@I][
M9,H6 I0)%EV!0_G65$0\XBII]^"T?%^JM>$D0Y0UL7R>8F[%VR@V[&ZLK29Y
MQU0HZ=C:#-:JA2:>1:)#@-P*+,V)&[8^N[?+[98-A[!>2#*#4=#3)=I!SKTL
M*;HH9DIWR00U#4O-TC<<^19=*,IX@LN-3'#9182.*"W/N+4.*2Y+MS1M-*S+
M*U+4ME0&BBV9Z>4UESQ?;BX$MEEEZHA?,HGV@CL%PO3TRN^MARH"G$ @!#D/
MM2?_]M)>^%^DK14W<';G>]PX6W_JK_26%[J*6# [\#_^A?_]<P4C=POI>/4R
MX$G\_U8Q90]/H#/=*N98V4[TR\=R%734A6<B.*3]9'Q[EY =_MG6<] )PACC
M3+$1'::A/M_:Z@3''W:#[<=/5C#E?EAD:00L\D,_>/)B^]FSU9 R?+EWCB56
M>A2AA#*R7.:KHV,UR_^OX@W;C-*[DG/O=VS'LQ^Q':78CF<_8CON)4FS(^D7
MZTCZ$.54$B,)T\5#]!S]XJ9YZYIY=<UP*3I!VI.AK%E-M;;A?6PY"74:0D4;
M<&M2J3G&X*E8NZ6]"A\Y>4J(+9##&*TC!,QL%)TMHH*E9BJOSMVF'!BX2J .
M[[/5<\75149IJ<J"O;%,(4'0&$&;0:5 5U,V[B<J'JG3)WB<CCBY3&U7%M*=
MYR*LD'&F,BD!RU7RR8G+I3ISTQ?+YA!56F^7L,_JDE/#G*M 1)F) E@Z KUL
M+4IJ0@FI)F//! 1A>$YI0U@_%&=<.K$9(*2IF*J+VKYEJ_I:WY3Q#D[9(A:6
MFDE@\-&5J:)V>0YT%F+9/PEU%WC<R0-W:DHGY_*E#^XL6U_"^Y"B$-R3?"Y?
M5<\"VCY-NAO6)'+L]&023J)0DB R."H9?N@X^CN;)8G\+^%$2</;S"4G:>5)
M5$*D-4=+NUOI3OO!*)HFS>HRE<J,Y,'M[XZ]N'J4CEE3-;Z.X:X5Z5E(9]9$
M+8DQP5:9)N.*+G0LAC9;DL:U-7)0=<FJCK% M<F6MA0-&RPXC]2I*EZ*.91R
MK76-*72 #W/14E(_=I@-)U0ME>+(H[2R/&*NVGF:ER9&3JZXPXEPJFI#BD8@
M'APE6F/B;B3Y&CTZ[<O(4#?&P&M<@A %J4YI=<_X.S).'EVQS"G37[[>* (#
M6U#0?HD'19I$=G2+2'J2*X;Z75)SW?E37^'4L=A-.,&:(VYHC+95XORF!JFI
M$@J H,,+;:BS<$)7-'?;Y"N>#Y&F+4Z>APOP(LJ*17.6JBU_7))#+%-_<*1H
MZ[2_PPQ;OF8.U.4KK-VGF][ 7OUM 7+6A&OW@?Z6H2\ , Y?7UU/M+#Q9S2Z
M[I<Q<6.DL 0[BRBF/1)'B;9;AN%R!QEI2EU(( BBXU.:?;:U7<\BBFF2_J(D
MW2;3.&(:H3'F[-2(0]LJSW,O23%EMUXT?(TN:_:C NV,PW B?6&9)K6T!4=0
M2Z/L$.]PU0+QSCB7?&-)/WMV,ZXA7\(.!XWJA<,>S?&  /0+[!BWAU[U*Q\U
MMA+":1*A$Y[0EP?[$==BY'>-!#, R $'B?W=&XV"5$!AN$C'W+(F1RKA:%(R
ML__;H1/=OL3]SJXP_)WJ4U^$M1M :9WLET_IRG +J)A7O:&=HA*</HL+<](#
M G)H&Y&,UKR8^;-KSJ@9)9*!50>PBKSBUHPD9Z_!S;>N]]7Q)3O5A]RX*?20
M8SR1:;HDO-(.Q2$+Y "_46MCIZFQ;2[B <*RH"99"8%U^Y_7-1IR2I:;T (?
M3VM8]H,D'>HT3+W9_)KPW.N*HSXX#U[Z0L$Q[/A-BKFA5CK^K(,SR#LYQ2:8
M2*KKY5T1$G'HD,G%@("!WJA]E4'A[+\2*'K;2>/2P9B%9G! 8%=ZA_F:<M'I
MG7;OL%=2IG44&X6J28X*9AN#.#^;4W<%6=>#NX)LU?6/N(N8+! 68^OYGTID
M1S7XQJ$)#/%Q@E"%9;JZT0U4HKH<<SI"GM@RPB@K(KC,I -X1<DYBXC:)1B.
M[VAS%(%B*LO<1$X1.=G4.C?U6DKX<%+P^23HQ%Z-#@I8),8!P%_5)'!6E,3@
M,"VM5>JI8T1RLD&%Z"-=ZAV_@;,'!S>>&2/%5VS R"W(I3N%Z.*#7"!$VT,B
MVA@V79B"H)XM),V,=N2914Q2;\D^0GLI2S;&D%=:O*W9=UU@WL<';589(34A
MXF1\TM[[&M+B.T)BI:1I9?V,-3OPX'C)<[<%]'AA6EWLV<:Z^3)YU5::9DHJ
M!9([_7E%XQ%2FT13,NT494T<\P+X,J7:$N[KNJ-!*3O;IP8TST6 #!5W@M&B
MT!*"),6HSQ0'+.:)2O5:!-VK#6)[T+JMV$8@E\S<(T<!(TWKIOK.%&%B+8^A
MT[:IA "_.*\.I=;U%\0P[+TBL>'>G,;6[+2.FJHQ99C+G>ITZ)26$Y@1D:5)
M-/8>>'!GXH5S)G15NI+AJYMS7*<T"/&LUB8>3)>JEM@Q7?JEB9=W/"%:IQ96
M,D5,A73=E.OZ:E.V;UBG'%SM&NI#K^.C-9DY87H:(8&##QNLATUVK>'.Y*%=
MN6H!G4>GQ$8UO46W"-*AP%Q8P<^ZH*!K#K^VQ2YQ_2,@9<X43/RVH0*"58AL
M?* <9R7WGZ"WNM0_WT%@U_2C-["S_WC=?S.@>"X4'<E-^Y;BPX#]]]_\$[=Y
M]4#HQ=JYEH<"//\1"E *!7C^(Q3@_EXM_</@8W]XV!L,@H_O>R>]H[=>%E6[
MA9("Y2DW^;)9R+%R!'77H_1MFW@O?9DQ9%/NI>>@!&#A:?CX-Y4L5';5";:W
MMI_>!X8V[.X>](*]WL'!X+B[US]\]^NCK4?T^;B[OZ\_?S%TE]&D.,='MWXR
MYWL,_$S-<R!P_=<CHLO7PQ,] >6CC%6L5P+$_TC3[G#?P Y_FB^#O2,$_?#7
M1SMP&MPFE0CMQE2!Q'7U\CIXZ=D<]H^7]^A-]T-OT!_V@O[AGNTM!_/"/R?W
M%VH]U:W#>XLP[L([+H0U.-DV%'?]U>! ^^5KU4\)N3[;^NE1_7;YSSVYV6-/
M?[K-O>6KIAYS_KP[CV]UXFZ28 6$* P&*B_0?W+[Y+5BFANB3;L!>;<X36.\
M:AW"?B;6>XN!K#OU.5K+!+@7/P2XD@#WXH< Y^@$WRZK??7NH4)$U6]9YF*A
M++7*=K6Z)ZE)ANKO*T*^5F[#HJ\O7Y_J">F1"69C*\[X2-($Y*G IGN@I014
M<1 T\>\[%S17G()4#P.Z8S@.B$1VD/#9%4>FMMSSR+FT59<15LJ&QH*\:1(,
M*!=Z#5^P5AK=GL1:9O --Q$$S9G85UY=JLPOWEH:2E03=RRVX\I",!(U=XM:
M_:62]A.LB3<XDS $?@2]C)Q-ODX6Y^6%L:QA2=L\CV-N"4(UY@I;[>CZ?GM1
M[G=&K V@B-PZXEP_@CJTL.NV5*JIH2VA5VB/:B642Y?92JD-#>=6W1NP0M7?
M^1"5IDMO.;?F#E=V^^Q!ZB5PM(-VO)N6E/6E>'6$=P,_,1UT<E,\!\%HJ#UG
M$T:QQ/,B5M\MP?-/9THH:4R/G]Y,HWMVJXK5WY<J<W62DU;P;A6,7Y>"<9UL
M7R_BF4V[54BO%7\^K74W=M=1\KF)GOSLV4_?:#^XN3+;O*O+":_64G][JGV]
M1GQ/<7+ME[=NG-N^361_Q-NE<RW&5[H-=\>\O@/'6LVV#>L$1U9*;65/]G7>
M<\OKIP>]9:ZL7R..13H-QDCY]WPWZWGWGW0WIRK*I,BN[2R($3^TN;*OJ%C^
M9T%M(H*_O#Z5#?BZ?U&&>$5!1_>;"G8?$A64C!+UNTYM,K]EZ^>Z%.;J[?9_
M='.:A$IQA-7G)+V,P\F9SD.A("E=[0LS*4Q$++=CP6!56\0;,U^BC(OOE2I\
M\?CP_TF4V[ H-UW/!F6Y\]FZF=R9LCQLQ#D!E 0+0X^S\'8+Z]V&4GTG,)1M
M>^W6+1CW@MNP[5G+W%<;]X):VYX8=U9JV[O?T3$F^JRF=%3M?W\"IT)3?;'#
MP?#D=&_8/SH<!&^/3H*3WKL^?-7%;X*CM\&@MW=ZTA_V>X,_+Q+(,WI36OC>
MY/#B,<H$:UCRD:H1[,;HASD(J>#&^AV \N>QA3ZO-=EYF@<7)7SYC79#;<S<
MN:'M=6LEUKJOBC1:J?5I!0 9F755S.([L:2C87^O]Y*R['(3+*U3%ZD1[@R>
MY1I!^3Q-)HY',:&$DMQD8IGN%E,U-LEZC=6+5 R<1=E6ZS& :\L?V5:ZMB<%
M^VD)'BQY>K90.& H*>7!2"68[5PX74-SZG"1ZY\R?A!$)5J2R9JC;U%6UBTQ
M9B%*/OEY-*=N-VZ9TYJV-YAWQL"N./[TRT*1?OGS!2#]"!A:S23=P:#_[O!#
M#ZXH$,X^K'BV.RQ=][K_9FV82C$3<0%+_X]J>^..:>5KN:$4RYE35RYI'A%A
M^BCKV9O!?DHJT")WWZJZM3?7,;SJH;6@0LG_M^[!:0_D_[U>_[?>?N>Z3? S
M\T$7IMX08THHD$(1I2I#?JQ.N3=:8<O$H9U35_O()06A2._#GOR!A=VG]0[J
M2MSU[8BZ3W$E2V_*VQ<C:Z=;ON(UL?^0=K6^XG#OKQCR.V@G*XD+N&.L+Z6(
M6TFC^ I:.SY'+\XAV>Z^:,M&SI9-T@4PR[M;!%6/#KZ&\&Y]%2LX;]^ & Q:
M!LFS')'ZKW]U FTT^O[Q)]\5 Z6<=&-DK2#E8>)#GYEOQL:*+1SWS5A_6S,O
MU6#OD3[46)W^9!&'&UJQ;3(<-*[/$3$?>6^[=.L8&&BT)<("*M[RKZMX>T#>
M,:G\O'NT_PG/R<_OAQ\.WOQ_4$L#!!0    ( *6 *EKL9A)+2PP  'E0   <
M    96$P,C(W,#<S,#%E>#4M,5]A;65S:71E+FAT;>U<;7,:.1+^3A7_0>>[
M3=E5 P8<D]AQ7(6-DW"+'1?@W=I/5V)&@#8SHXFD 9-??]V2!@9[G)>-2<PN
M6UNQF9%:K59WZ^D7<_)N<-D]+9=.WEVTVO"3X'\G@\Z@>W%ZLF]_PMM]]_KD
M['W[#](?_-&]>+TS$K$^)O5:HLF 1TR1*S8C/1'1V+,//-)GDH]V8"),O?[6
M>:](1.68Q\<$A]9>$<UN=86&? R/)!]/],[IR9OW5X,\X<J(1CR<'W^)M!FK
M^"=F.0%*9Z<7MQ,^Y+I<.JS63_;/0 !('7Y<;\0.GL5#E;RZR_2@==:](.<7
MW6[_NG7>N7K[>J>V8SY?M]KM[/,W;VS& SW!H;5?=HS>G QZ?T4QK+ZUOYV!
M*9.:^S3,Q*E%LN"JB4R=="[?DG[O_/4.NSVLU/]7J]6K?R;C'=+J#E[O[*!Z
MM[^' ;?6<[/6]ZK&8^I!?\*2A,K LYN[3,.0PZP>]R>:2?*,1B"I=_"O%C$!
M-5C1&"..I[2;@YIEJB?\#VS$PA"V<!W23_1ILPTC+5=_"/G!,Q/Q-WA;KS<J
MH(N'3YO_1KU1;1X>5%^^J+D#B"B/-X;GNF5O1&^?-LNSV:RJG+U&QE"KOHAR
M/!LO!?_TK)/=-^[\]-$OHS]3I?EHOO[KZ,FS_5\:IU3.RZ5ZS2.-6N-PXW:P
MH8(' '9R<_I;IU4N770OS@>]]U>=<W+9ZG1/]F].UX_'UK"E%KSEFI5+G=BO
M;ASWS=J+<@G 1#B<D[Z6C.F-VT(_->*'.XQ<7YZ11OWYQFVAS;047 .8NP0
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MS'69U:R23HS-MS;CRE6VJ@$L@3!@F081BLM!:$0Q:'6.%&9-QL(D9<LE%Y:
MH@K%%AL JJXC,W"UXK[K_GM1W,%N78A,0Y;A[*Q5,P^>LVZ?1(HH#<=&X";_
MZF0"OL(T?A[6C@KZ/5':[!:!N8)-+C2%F@ CZP$?"_!"L3U(=) AG2D'ZD$<
M5@#MM^?=+4#_@98?<.6'E$?F1 1$2F-[JA@8!E,.BC<7*9ZX"1$A N42XE:
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MFM.'C6,_C6K_E9K&*(8T-//=.$$V-)K7L[U'_]L5_]F+_B?L+U!+ P04
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M21P%UKC>SR3R9*5%.D*LPD4'$APE!6!5*::-1[70$-4'\ER='(J\RPD\;\
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MGS;!_!?8-^P>4U ,OFH$ZDZJIH^_ 5!+ P04    " "E@"I:;#JL4?T*  "
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M$U8\"JR&[BT"98^25H+LHH1@*&*IYG+G=G%?9O9X7/5E$AS2*PI"PX&2;[[
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M^1]02P$"% ,4    " "E@"I:<FEQ]2D:  #7BP  &               @ $
M    96$P,C(W,#<S+3AK7V%M97-I=&4N:'1M4$L! A0#%     @ I8 J6J;!
M.LL$G0  O\\# !P              ( !7QH  &5A,#(R-S W,S Q97@Q+3%?
M86UE<VET92YH=&U02P$"% ,4    " "E@"I:.".D\.,U  "<'P$ '
M        @ &=MP  96$P,C(W,#<S,#%E>#0M,5]A;65S:71E+FAT;5!+ 0(4
M Q0    ( *6 *EKL9A)+2PP  'E0   <              "  ;KM  !E83 R
M,C<P-S,P,65X-2TQ7V%M97-I=&4N:'1M4$L! A0#%     @ I8 J6ME4<7X?
M"0  &B8  !T              ( !/_H  &5A,#(R-S W,S Q97@Y.2TQ7V%M
M97-I=&4N:'1M4$L! A0#%     @ I8 J6FAUA^7^"   (AX  !T
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2      H "@#* @  /BP!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>ea0227073-8k_amesite_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vde0-20250107.xsd" xlink:type="simple"/>
    <context id="AsOf2025-01-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001807166</identifier>
        </entity>
        <period>
            <startDate>2025-01-07</startDate>
            <endDate>2025-01-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-01-07" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-01-07" id="Fact000004">0001807166</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-01-07" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-01-07" id="Fact000010">2025-01-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-01-07" id="Fact000011">Amesite Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-01-07" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-01-07" id="Fact000013">001-39553</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-01-07" id="Fact000014">82-3431718</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-01-07" id="Fact000015">607 Shelby Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-01-07" id="Fact000016">Suite 700 PMB 214</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-01-07" id="Fact000017">Detroit</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-01-07" id="Fact000018">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-01-07" id="Fact000019">48226</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-01-07" id="Fact000020">734</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-01-07" id="Fact000021">876-8130</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-01-07" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-01-07" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-01-07" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-01-07" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-01-07" id="Fact000026">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-01-07" id="Fact000027">AMST</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-01-07" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-01-07" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-01-07" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
